{
  "entities": [
    {
      "id": "E1",
      "type": "Target",
      "name": "type 4 phosphodiesterase",
      "attributes": {
        "target_type": "enzyme"
      },
      "source_chunk_ids": [
        "965d5e31ae90be5dca185dacd7b62c07"
      ],
      "confidence": 0.9,
      "evidence": "type 4 phosphodiesterase (PDE4)",
      "verified": true
    },
    {
      "id": "E2",
      "type": "Target",
      "name": "PDE4",
      "attributes": {
        "target_type": "enzyme"
      },
      "source_chunk_ids": [
        "965d5e31ae90be5dca185dacd7b62c07"
      ],
      "confidence": 0.95,
      "evidence": "PDE4",
      "verified": true
    },
    {
      "id": "E3",
      "type": "Target",
      "name": "PDE4D",
      "attributes": {
        "target_type": "enzyme"
      },
      "source_chunk_ids": [
        "965d5e31ae90be5dca185dacd7b62c07"
      ],
      "confidence": 0.85,
      "evidence": "PDE4D",
      "verified": true
    },
    {
      "id": "E4",
      "type": "Target",
      "name": "PDE4B",
      "attributes": {
        "target_type": "enzyme"
      },
      "source_chunk_ids": [
        "965d5e31ae90be5dca185dacd7b62c07"
      ],
      "confidence": 0.85,
      "evidence": "PDE4B",
      "verified": true
    },
    {
      "id": "E5",
      "type": "Target",
      "name": "cAMP signaling pathways",
      "attributes": {
        "target_type": "pathway"
      },
      "source_chunk_ids": [
        "965d5e31ae90be5dca185dacd7b62c07"
      ],
      "confidence": 0.8,
      "evidence": "cAMP signaling pathways",
      "verified": true
    },
    {
      "id": "E6",
      "type": "Condition",
      "name": "depression",
      "attributes": {
        "condition_type": "disease"
      },
      "source_chunk_ids": [
        "965d5e31ae90be5dca185dacd7b62c07"
      ],
      "confidence": 0.9,
      "evidence": "antidepressants",
      "verified": true
    },
    {
      "id": "E7",
      "type": "Effect",
      "name": "antidepressant effects",
      "attributes": {
        "level": "systemic",
        "valence": "positive"
      },
      "source_chunk_ids": [
        "965d5e31ae90be5dca185dacd7b62c07"
      ],
      "confidence": 0.85,
      "evidence": "antidepressant effects",
      "verified": true
    },
    {
      "id": "E1",
      "type": "Study",
      "name": "Helmut Wachtel research",
      "attributes": {
        "year": "over 20 years ago",
        "affiliation": "Schering AG Pharmaceuticals"
      },
      "source_chunk_ids": [
        "932852e578657d1f1cdd15cd076ead6a"
      ],
      "confidence": 0.9,
      "evidence": "Research by Helmut Wachtel at Schering AG Pharmaceuticals",
      "verified": true
    },
    {
      "id": "E2",
      "type": "Evidence",
      "name": "in vitro study",
      "attributes": {
        "evidence_level": 2
      },
      "source_chunk_ids": [
        "932852e578657d1f1cdd15cd076ead6a"
      ],
      "confidence": 0.8,
      "evidence": "demonstrated that the then-novel compound rolipram",
      "verified": true
    },
    {
      "id": "E3",
      "type": "Compound",
      "name": "rolipram",
      "attributes": {},
      "source_chunk_ids": [
        "932852e578657d1f1cdd15cd076ead6a"
      ],
      "confidence": 0.95,
      "evidence": "compound rolipram",
      "verified": true
    },
    {
      "id": "E4",
      "type": "Target",
      "name": "cAMP phosphodiesterase",
      "attributes": {
        "target_type": "enzyme"
      },
      "source_chunk_ids": [
        "932852e578657d1f1cdd15cd076ead6a"
      ],
      "confidence": 0.85,
      "evidence": "inhibitors of cAMP phosphodiesterase (PDE)",
      "verified": true
    },
    {
      "id": "E5",
      "type": "Target",
      "name": "PDE4",
      "attributes": {
        "target_type": "enzyme"
      },
      "source_chunk_ids": [
        "932852e578657d1f1cdd15cd076ead6a"
      ],
      "confidence": 0.9,
      "evidence": "type 4 PDE (PDE4)",
      "verified": true
    },
    {
      "id": "E6",
      "type": "Effect",
      "name": "CNS activity",
      "attributes": {
        "level": "systemic",
        "valence": "positive"
      },
      "source_chunk_ids": [
        "932852e578657d1f1cdd15cd076ead6a"
      ],
      "confidence": 0.8,
      "evidence": "have CNS activity",
      "verified": true
    },
    {
      "id": "E7",
      "type": "Effect",
      "name": "antidepressant efficacy",
      "attributes": {
        "level": "systemic",
        "valence": "positive"
      },
      "source_chunk_ids": [
        "932852e578657d1f1cdd15cd076ead6a"
      ],
      "confidence": 0.85,
      "evidence": "indicative of antidepressant efficacy",
      "verified": true
    },
    {
      "id": "E8",
      "type": "Study",
      "name": "clinical trial [3]",
      "attributes": {
        "design": "clinical trial"
      },
      "source_chunk_ids": [
        "932852e578657d1f1cdd15cd076ead6a"
      ],
      "confidence": 0.75,
      "evidence": "borne out later in a clinical trial",
      "verified": true
    },
    {
      "id": "E9",
      "type": "Evidence",
      "name": "clinical trial evidence",
      "attributes": {
        "evidence_level": 4
      },
      "source_chunk_ids": [
        "932852e578657d1f1cdd15cd076ead6a"
      ],
      "confidence": 0.7,
      "evidence": "clinical trial",
      "verified": true
    },
    {
      "id": "E10",
      "type": "Condition",
      "name": "depression",
      "attributes": {
        "condition_type": "disorder"
      },
      "source_chunk_ids": [
        "932852e578657d1f1cdd15cd076ead6a"
      ],
      "confidence": 0.9,
      "evidence": "therapeutic utility in depression",
      "verified": true
    },
    {
      "id": "E11",
      "type": "Condition",
      "name": "inflammatory disorders",
      "attributes": {
        "condition_type": "disorder"
      },
      "source_chunk_ids": [
        "932852e578657d1f1cdd15cd076ead6a"
      ],
      "confidence": 0.8,
      "evidence": "inflammatory and immunological disorders",
      "verified": true
    },
    {
      "id": "E12",
      "type": "Condition",
      "name": "immunological disorders",
      "attributes": {
        "condition_type": "disorder"
      },
      "source_chunk_ids": [
        "932852e578657d1f1cdd15cd076ead6a"
      ],
      "confidence": 0.8,
      "evidence": "inflammatory and immunological disorders",
      "verified": true
    },
    {
      "id": "E13",
      "type": "Target",
      "name": "PDE4 subtypes",
      "attributes": {
        "target_type": "enzyme"
      },
      "source_chunk_ids": [
        "932852e578657d1f1cdd15cd076ead6a"
      ],
      "confidence": 0.75,
      "evidence": "four PDE4 subtypes",
      "verified": true
    },
    {
      "id": "E14",
      "type": "Target",
      "name": "HARBS",
      "attributes": {
        "target_type": "binding site"
      },
      "source_chunk_ids": [
        "932852e578657d1f1cdd15cd076ead6a"
      ],
      "confidence": 0.7,
      "evidence": "high-affinity rolipram-binding sites (HARBS)",
      "verified": true
    },
    {
      "id": "E15",
      "type": "Target",
      "name": "LARBS",
      "attributes": {
        "target_type": "binding site"
      },
      "source_chunk_ids": [
        "932852e578657d1f1cdd15cd076ead6a"
      ],
      "confidence": 0.7,
      "evidence": "low-affinity rolipram-binding sites (LARBS)",
      "verified": true
    },
    {
      "id": "E1",
      "type": "Target",
      "name": "PDE enzymes",
      "attributes": {
        "target_type": "enzyme family"
      },
      "source_chunk_ids": [
        "3a627f2ba9f61ab88dcc03d98345355c"
      ],
      "confidence": 0.95,
      "evidence": "PDE enzymes comprise an eleven-family group",
      "verified": true
    },
    {
      "id": "E2",
      "type": "Target",
      "name": "PDE1\u2013PDE11",
      "attributes": {
        "target_type": "enzyme family"
      },
      "source_chunk_ids": [
        "3a627f2ba9f61ab88dcc03d98345355c"
      ],
      "confidence": 0.9,
      "evidence": "PDE1\u2013PDE11",
      "verified": true
    },
    {
      "id": "E3",
      "type": "Target",
      "name": "cAMP",
      "attributes": {
        "target_type": "substrate"
      },
      "source_chunk_ids": [
        "3a627f2ba9f61ab88dcc03d98345355c"
      ],
      "confidence": 0.85,
      "evidence": "hydrolyze cAMP",
      "verified": true
    },
    {
      "id": "E4",
      "type": "Target",
      "name": "cGMP",
      "attributes": {
        "target_type": "substrate"
      },
      "source_chunk_ids": [
        "3a627f2ba9f61ab88dcc03d98345355c"
      ],
      "confidence": 0.85,
      "evidence": "hydrolyze cGMP",
      "verified": true
    },
    {
      "id": "E5",
      "type": "Target",
      "name": "Ca^{2+}",
      "attributes": {
        "target_type": "modulator"
      },
      "source_chunk_ids": [
        "3a627f2ba9f61ab88dcc03d98345355c"
      ],
      "confidence": 0.8,
      "evidence": "sensitivity to modulators (e.g. Ca^{2+})",
      "verified": true
    },
    {
      "id": "E6",
      "type": "Target",
      "name": "calmodulin",
      "attributes": {
        "target_type": "modulator"
      },
      "source_chunk_ids": [
        "3a627f2ba9f61ab88dcc03d98345355c"
      ],
      "confidence": 0.8,
      "evidence": "sensitivity to modulators (e.g. calmodulin)",
      "verified": true
    },
    {
      "id": "E7",
      "type": "Target",
      "name": "pharmacological inhibitors",
      "attributes": {
        "target_type": "inhibitor"
      },
      "source_chunk_ids": [
        "3a627f2ba9f61ab88dcc03d98345355c"
      ],
      "confidence": 0.75,
      "evidence": "sensitivity to pharmacological inhibitors",
      "verified": true
    },
    {
      "id": "E1",
      "type": "Target",
      "name": "PDE4 enzyme family",
      "attributes": {
        "target_type": "enzyme"
      },
      "source_chunk_ids": [
        "7f5a74ac13da75da462287b1cb003d32"
      ],
      "confidence": 0.95,
      "evidence": "PDE4 enzyme family",
      "verified": true
    },
    {
      "id": "E2",
      "type": "Target",
      "name": "PDE4A",
      "attributes": {
        "target_type": "enzyme"
      },
      "source_chunk_ids": [
        "7f5a74ac13da75da462287b1cb003d32"
      ],
      "confidence": 0.9,
      "evidence": "PDE4A",
      "verified": true
    },
    {
      "id": "E3",
      "type": "Target",
      "name": "PDE4B",
      "attributes": {
        "target_type": "enzyme"
      },
      "source_chunk_ids": [
        "7f5a74ac13da75da462287b1cb003d32"
      ],
      "confidence": 0.9,
      "evidence": "PDE4B",
      "verified": true
    },
    {
      "id": "E4",
      "type": "Target",
      "name": "PDE4C",
      "attributes": {
        "target_type": "enzyme"
      },
      "source_chunk_ids": [
        "7f5a74ac13da75da462287b1cb003d32"
      ],
      "confidence": 0.9,
      "evidence": "PDE4C",
      "verified": true
    },
    {
      "id": "E5",
      "type": "Target",
      "name": "PDE4D",
      "attributes": {
        "target_type": "enzyme"
      },
      "source_chunk_ids": [
        "7f5a74ac13da75da462287b1cb003d32"
      ],
      "confidence": 0.9,
      "evidence": "PDE4D",
      "verified": true
    },
    {
      "id": "E6",
      "type": "Effect",
      "name": "reward",
      "attributes": {
        "level": "behavioral",
        "valence": "positive"
      },
      "source_chunk_ids": [
        "7f5a74ac13da75da462287b1cb003d32"
      ],
      "confidence": 0.8,
      "evidence": "involved in reward",
      "verified": true
    },
    {
      "id": "E7",
      "type": "Effect",
      "name": "affect",
      "attributes": {
        "level": "behavioral",
        "valence": "neutral"
      },
      "source_chunk_ids": [
        "7f5a74ac13da75da462287b1cb003d32"
      ],
      "confidence": 0.8,
      "evidence": "involved in affect",
      "verified": true
    },
    {
      "id": "E1",
      "type": "Compound",
      "name": "Rolipram",
      "attributes": {},
      "source_chunk_ids": [
        "daf511dbaf73a527055607849218e6c4"
      ],
      "confidence": 0.95,
      "evidence": "Rolipram",
      "verified": true
    },
    {
      "id": "E2",
      "type": "CompoundClass",
      "name": "PDE4 inhibitors",
      "attributes": {},
      "source_chunk_ids": [
        "daf511dbaf73a527055607849218e6c4"
      ],
      "confidence": 0.9,
      "evidence": "PDE4 inhibitors",
      "verified": true
    },
    {
      "id": "E3",
      "type": "Compound",
      "name": "Ro201724",
      "attributes": {},
      "source_chunk_ids": [
        "daf511dbaf73a527055607849218e6c4"
      ],
      "confidence": 0.85,
      "evidence": "Ro201724",
      "verified": true
    },
    {
      "id": "E4",
      "type": "Compound",
      "name": "ICI63197",
      "attributes": {},
      "source_chunk_ids": [
        "daf511dbaf73a527055607849218e6c4"
      ],
      "confidence": 0.85,
      "evidence": "ICI63197",
      "verified": true
    },
    {
      "id": "E5",
      "type": "Effect",
      "name": "antidepressant-like effects",
      "attributes": {
        "level": "behavioral",
        "valence": "positive"
      },
      "source_chunk_ids": [
        "daf511dbaf73a527055607849218e6c4"
      ],
      "confidence": 0.9,
      "evidence": "produce antidepressant-like effects",
      "verified": true
    },
    {
      "id": "E1",
      "type": "Target",
      "name": "PDE4",
      "attributes": {
        "target_type": "enzyme"
      },
      "source_chunk_ids": [
        "f287f72f1c1f1c7a6de4e2fdf97bc536"
      ],
      "confidence": 0.95,
      "evidence": "Type 4 phosphodiesterase (PDE4) enzyme",
      "verified": true
    },
    {
      "id": "E2",
      "type": "Target",
      "name": "PDE4A",
      "attributes": {
        "target_type": "enzyme"
      },
      "source_chunk_ids": [
        "f287f72f1c1f1c7a6de4e2fdf97bc536"
      ],
      "confidence": 0.9,
      "evidence": "PDE4A",
      "verified": true
    },
    {
      "id": "E3",
      "type": "Target",
      "name": "PDE4B",
      "attributes": {
        "target_type": "enzyme"
      },
      "source_chunk_ids": [
        "f287f72f1c1f1c7a6de4e2fdf97bc536"
      ],
      "confidence": 0.9,
      "evidence": "PDE4B",
      "verified": true
    },
    {
      "id": "E4",
      "type": "Target",
      "name": "PDE4C",
      "attributes": {
        "target_type": "enzyme"
      },
      "source_chunk_ids": [
        "f287f72f1c1f1c7a6de4e2fdf97bc536"
      ],
      "confidence": 0.9,
      "evidence": "PDE4C",
      "verified": true
    },
    {
      "id": "E5",
      "type": "Target",
      "name": "PDE4D",
      "attributes": {
        "target_type": "enzyme"
      },
      "source_chunk_ids": [
        "f287f72f1c1f1c7a6de4e2fdf97bc536"
      ],
      "confidence": 0.9,
      "evidence": "PDE4D",
      "verified": true
    },
    {
      "id": "E6",
      "type": "Target",
      "name": "PKA",
      "attributes": {
        "target_type": "enzyme"
      },
      "source_chunk_ids": [
        "f287f72f1c1f1c7a6de4e2fdf97bc536"
      ],
      "confidence": 0.8,
      "evidence": "PKA phosphorylation",
      "verified": true
    },
    {
      "id": "E7",
      "type": "Target",
      "name": "ERK2",
      "attributes": {
        "target_type": "enzyme"
      },
      "source_chunk_ids": [
        "f287f72f1c1f1c7a6de4e2fdf97bc536"
      ],
      "confidence": 0.8,
      "evidence": "ERK2 phosphorylation",
      "verified": true
    },
    {
      "id": "E1",
      "type": "Target",
      "name": "PDE4",
      "attributes": {
        "target_type": "enzyme"
      },
      "source_chunk_ids": [
        "d65e820b041e8c5f6f6f4882e90a8656"
      ],
      "confidence": 0.95,
      "evidence": "Type 4 phosphodiesterase (PDE4) enzymes",
      "verified": true
    },
    {
      "id": "E2",
      "type": "Target",
      "name": "PDE4A",
      "attributes": {
        "target_type": "enzyme"
      },
      "source_chunk_ids": [
        "d65e820b041e8c5f6f6f4882e90a8656"
      ],
      "confidence": 0.9,
      "evidence": "PDE4A",
      "verified": true
    },
    {
      "id": "E3",
      "type": "Target",
      "name": "PDE4B",
      "attributes": {
        "target_type": "enzyme"
      },
      "source_chunk_ids": [
        "d65e820b041e8c5f6f6f4882e90a8656"
      ],
      "confidence": 0.9,
      "evidence": "PDE4B",
      "verified": true
    },
    {
      "id": "E4",
      "type": "Target",
      "name": "PDE4C",
      "attributes": {
        "target_type": "enzyme"
      },
      "source_chunk_ids": [
        "d65e820b041e8c5f6f6f4882e90a8656"
      ],
      "confidence": 0.9,
      "evidence": "PDE4C",
      "verified": true
    },
    {
      "id": "E5",
      "type": "Target",
      "name": "PDE4D",
      "attributes": {
        "target_type": "enzyme"
      },
      "source_chunk_ids": [
        "d65e820b041e8c5f6f6f4882e90a8656"
      ],
      "confidence": 0.9,
      "evidence": "PDE4D",
      "verified": true
    },
    {
      "id": "E6",
      "type": "Target",
      "name": "ERK2",
      "attributes": {
        "target_type": "kinase"
      },
      "source_chunk_ids": [
        "d65e820b041e8c5f6f6f4882e90a8656"
      ],
      "confidence": 0.85,
      "evidence": "extracellular signal-regulated kinase (ERK2)",
      "verified": true
    },
    {
      "id": "E1",
      "type": "Effect",
      "name": "decrease time of immobility in forced-swim test",
      "attributes": {
        "level": "behavioral",
        "valence": "negative"
      },
      "source_chunk_ids": [
        "9cf7c3476eaf50eb155077d28a3c7195"
      ],
      "confidence": 0.85,
      "evidence": "decrease time of immobility in forced-swim test",
      "verified": true
    },
    {
      "id": "E2",
      "type": "Effect",
      "name": "decrease response rate under DRL schedule",
      "attributes": {
        "level": "behavioral",
        "valence": "negative"
      },
      "source_chunk_ids": [
        "9cf7c3476eaf50eb155077d28a3c7195"
      ],
      "confidence": 0.8,
      "evidence": "decrease response rate under DRL schedule",
      "verified": true
    },
    {
      "id": "E3",
      "type": "Effect",
      "name": "increase reinforcement rate under DRL schedule",
      "attributes": {
        "level": "behavioral",
        "valence": "positive"
      },
      "source_chunk_ids": [
        "9cf7c3476eaf50eb155077d28a3c7195"
      ],
      "confidence": 0.8,
      "evidence": "increase reinforcement rate under DRL schedule",
      "verified": true
    },
    {
      "id": "E4",
      "type": "Effect",
      "name": "reverse effects of chronic mild stress",
      "attributes": {
        "level": "behavioral",
        "valence": "positive"
      },
      "source_chunk_ids": [
        "9cf7c3476eaf50eb155077d28a3c7195"
      ],
      "confidence": 0.8,
      "evidence": "reverse effects of chronic mild stress",
      "verified": true
    },
    {
      "id": "E5",
      "type": "Effect",
      "name": "normalize behavioral deficits in Flinders sensitive-line rats",
      "attributes": {
        "level": "behavioral",
        "valence": "positive"
      },
      "source_chunk_ids": [
        "9cf7c3476eaf50eb155077d28a3c7195"
      ],
      "confidence": 0.75,
      "evidence": "normalize deficits in Flinders sensitive-line rats",
      "verified": true
    },
    {
      "id": "E6",
      "type": "Effect",
      "name": "normalize behavioral deficits in olfactory-bulb-cocaineized rats",
      "attributes": {
        "level": "behavioral",
        "valence": "positive"
      },
      "source_chunk_ids": [
        "9cf7c3476eaf50eb155077d28a3c7195"
      ],
      "confidence": 0.75,
      "evidence": "normalize deficits in olfactory-bulb-cocaineized rats",
      "verified": true
    },
    {
      "id": "E7",
      "type": "Effect",
      "name": "antagonize effects of reserpine",
      "attributes": {
        "level": "behavioral",
        "valence": "positive"
      },
      "source_chunk_ids": [
        "9cf7c3476eaf50eb155077d28a3c7195"
      ],
      "confidence": 0.8,
      "evidence": "antagonize effects of reserpine",
      "verified": true
    },
    {
      "id": "E8",
      "type": "Effect",
      "name": "potentiate yohimbine-induced toxicity",
      "attributes": {
        "level": "behavioral",
        "valence": "negative"
      },
      "source_chunk_ids": [
        "9cf7c3476eaf50eb155077d28a3c7195"
      ],
      "confidence": 0.8,
      "evidence": "potentiate yohimbine-induced toxicity",
      "verified": true
    },
    {
      "id": "E9",
      "type": "Effect",
      "name": "typical antidepressant effects",
      "attributes": {
        "level": "behavioral",
        "valence": "positive"
      },
      "source_chunk_ids": [
        "9cf7c3476eaf50eb155077d28a3c7195"
      ],
      "confidence": 0.7,
      "evidence": "effects typical of antidepressant drugs",
      "verified": true
    },
    {
      "id": "E10",
      "type": "Target",
      "name": "PDE4",
      "attributes": {
        "target_type": "enzyme"
      },
      "source_chunk_ids": [
        "9cf7c3476eaf50eb155077d28a3c7195"
      ],
      "confidence": 0.9,
      "evidence": "PDE4 also appears to be involved",
      "verified": true
    },
    {
      "id": "E11",
      "type": "Target",
      "name": "CREB",
      "attributes": {
        "target_type": "protein"
      },
      "source_chunk_ids": [
        "9cf7c3476eaf50eb155077d28a3c7195"
      ],
      "confidence": 0.85,
      "evidence": "CREB (cAMP response element-binding protein)",
      "verified": true
    },
    {
      "id": "E12",
      "type": "Effect",
      "name": "induction of neurogenesis in hippocampus",
      "attributes": {
        "level": "cellular",
        "valence": "positive"
      },
      "source_chunk_ids": [
        "9cf7c3476eaf50eb155077d28a3c7195"
      ],
      "confidence": 0.8,
      "evidence": "induction of neurogenesis in hippocampus",
      "verified": true
    },
    {
      "id": "E13",
      "type": "Effect",
      "name": "induce neurogenesis",
      "attributes": {
        "level": "cellular",
        "valence": "positive"
      },
      "source_chunk_ids": [
        "9cf7c3476eaf50eb155077d28a3c7195"
      ],
      "confidence": 0.75,
      "evidence": "ability to induce neurogenesis",
      "verified": true
    },
    {
      "id": "E14",
      "type": "Effect",
      "name": "mediate late-developing behavioral effects",
      "attributes": {
        "level": "behavioral",
        "valence": "positive"
      },
      "source_chunk_ids": [
        "9cf7c3476eaf50eb155077d28a3c7195"
      ],
      "confidence": 0.7,
      "evidence": "important in mediating late-developing effects",
      "verified": true
    },
    {
      "id": "E1",
      "type": "Evidence",
      "name": "clinical studies",
      "attributes": {
        "evidence_level": 4
      },
      "source_chunk_ids": [
        "faa4b4cea1353cd24eecfad1b58d6bda"
      ],
      "confidence": 0.9,
      "evidence": "clinical studies",
      "verified": true
    },
    {
      "id": "E2",
      "type": "Target",
      "name": "PDE4",
      "attributes": {
        "target_type": "enzyme"
      },
      "source_chunk_ids": [
        "faa4b4cea1353cd24eecfad1b58d6bda"
      ],
      "confidence": 0.95,
      "evidence": "PDE4 inhibitors",
      "verified": true
    },
    {
      "id": "E3",
      "type": "Effect",
      "name": "antidepressant efficacy",
      "attributes": {
        "level": "systemic",
        "valence": "positive"
      },
      "source_chunk_ids": [
        "faa4b4cea1353cd24eecfad1b58d6bda"
      ],
      "confidence": 0.85,
      "evidence": "antidepressant efficacy",
      "verified": true
    },
    {
      "id": "E4",
      "type": "Compound",
      "name": "rolipram",
      "attributes": {},
      "source_chunk_ids": [
        "faa4b4cea1353cd24eecfad1b58d6bda"
      ],
      "confidence": 0.95,
      "evidence": "rolipram",
      "verified": true
    },
    {
      "id": "E5",
      "type": "AdverseEvent",
      "name": "emetic actions",
      "attributes": {
        "severity": "troublesome"
      },
      "source_chunk_ids": [
        "faa4b4cea1353cd24eecfad1b58d6bda"
      ],
      "confidence": 0.8,
      "evidence": "emetic actions",
      "verified": true
    },
    {
      "id": "E6",
      "type": "AdverseEvent",
      "name": "sedative actions",
      "attributes": {
        "severity": "troublesome"
      },
      "source_chunk_ids": [
        "faa4b4cea1353cd24eecfad1b58d6bda"
      ],
      "confidence": 0.8,
      "evidence": "sedative actions",
      "verified": true
    },
    {
      "id": "E7",
      "type": "Target",
      "name": "PDE4A",
      "attributes": {
        "target_type": "enzyme"
      },
      "source_chunk_ids": [
        "faa4b4cea1353cd24eecfad1b58d6bda"
      ],
      "confidence": 0.85,
      "evidence": "PDE4A",
      "verified": true
    },
    {
      "id": "E8",
      "type": "Target",
      "name": "PDE4B",
      "attributes": {
        "target_type": "enzyme"
      },
      "source_chunk_ids": [
        "faa4b4cea1353cd24eecfad1b58d6bda"
      ],
      "confidence": 0.85,
      "evidence": "PDE4B",
      "verified": true
    },
    {
      "id": "E9",
      "type": "Target",
      "name": "PDE4D",
      "attributes": {
        "target_type": "enzyme"
      },
      "source_chunk_ids": [
        "faa4b4cea1353cd24eecfad1b58d6bda"
      ],
      "confidence": 0.85,
      "evidence": "PDE4D",
      "verified": true
    },
    {
      "id": "E1",
      "type": "Target",
      "name": "PDE4",
      "attributes": {
        "target_type": "enzyme"
      },
      "source_chunk_ids": [
        "86ecbea6e66d2e9eaa19330f2e576700"
      ],
      "confidence": 0.95,
      "evidence": "PDE4 is a regulated component",
      "verified": true
    },
    {
      "id": "E2",
      "type": "Target",
      "name": "\u03b2-adrenoceptors",
      "attributes": {
        "target_type": "receptor"
      },
      "source_chunk_ids": [
        "86ecbea6e66d2e9eaa19330f2e576700"
      ],
      "confidence": 0.9,
      "evidence": "\u03b2-adrenoceptors in rat cerebral cortex",
      "verified": true
    },
    {
      "id": "E3",
      "type": "Target",
      "name": "noradrenaline-mediated neurotransmission",
      "attributes": {
        "target_type": "process"
      },
      "source_chunk_ids": [
        "86ecbea6e66d2e9eaa19330f2e576700"
      ],
      "confidence": 0.85,
      "evidence": "noradrenaline-mediated neurotransmission",
      "verified": true
    },
    {
      "id": "E4",
      "type": "Effect",
      "name": "antidepressant effects",
      "attributes": {
        "level": "systemic",
        "valence": "positive"
      },
      "source_chunk_ids": [
        "86ecbea6e66d2e9eaa19330f2e576700"
      ],
      "confidence": 0.8,
      "evidence": "produce antidepressant effects",
      "verified": true
    },
    {
      "id": "E5",
      "type": "Effect",
      "name": "inhibition of PDE4",
      "attributes": {
        "level": "molecular",
        "valence": "negative"
      },
      "source_chunk_ids": [
        "86ecbea6e66d2e9eaa19330f2e576700"
      ],
      "confidence": 0.75,
      "evidence": "Inhibition of PDE4",
      "verified": true
    },
    {
      "id": "E1",
      "type": "Target",
      "name": "PDE4",
      "attributes": {
        "target_type": "enzyme"
      },
      "source_chunk_ids": [
        "21a98f83de243122f2a63ceebb9ace2a"
      ],
      "confidence": 0.9,
      "evidence": "involvement of PDE4",
      "verified": true
    },
    {
      "id": "E2",
      "type": "Target",
      "name": "5-HT-mediated neurotransmission",
      "attributes": {
        "target_type": "process"
      },
      "source_chunk_ids": [
        "21a98f83de243122f2a63ceebb9ace2a"
      ],
      "confidence": 0.85,
      "evidence": "5-HT-mediated neurotransmission",
      "verified": true
    },
    {
      "id": "E3",
      "type": "Target",
      "name": "adenylyl cyclase",
      "attributes": {
        "target_type": "enzyme"
      },
      "source_chunk_ids": [
        "21a98f83de243122f2a63ceebb9ace2a"
      ],
      "confidence": 0.8,
      "evidence": "coupled positively to adenylyl cyclase",
      "verified": true
    },
    {
      "id": "E4",
      "type": "Target",
      "name": "PDE4 inhibitors",
      "attributes": {
        "target_type": "enzyme inhibitor"
      },
      "source_chunk_ids": [
        "21a98f83de243122f2a63ceebb9ace2a"
      ],
      "confidence": 0.75,
      "evidence": "PDE4 inhibitors enhance aspects",
      "verified": true
    },
    {
      "id": "E5",
      "type": "Target",
      "name": "cAMP",
      "attributes": {
        "target_type": "molecule"
      },
      "source_chunk_ids": [
        "21a98f83de243122f2a63ceebb9ace2a"
      ],
      "confidence": 0.8,
      "evidence": "involve cAMP",
      "verified": true
    },
    {
      "id": "E6",
      "type": "Compound",
      "name": "fluoxetine",
      "attributes": {},
      "source_chunk_ids": [
        "21a98f83de243122f2a63ceebb9ace2a"
      ],
      "confidence": 0.9,
      "evidence": "inhibitor of 5-HT reuptake such as fluoxetine",
      "verified": true
    },
    {
      "id": "E7",
      "type": "Target",
      "name": "5-HT reuptake",
      "attributes": {
        "target_type": "process"
      },
      "source_chunk_ids": [
        "21a98f83de243122f2a63ceebb9ace2a"
      ],
      "confidence": 0.85,
      "evidence": "inhibitor of 5-HT reuptake",
      "verified": true
    },
    {
      "id": "E8",
      "type": "Target",
      "name": "PDE4A",
      "attributes": {
        "target_type": "enzyme"
      },
      "source_chunk_ids": [
        "21a98f83de243122f2a63ceebb9ace2a"
      ],
      "confidence": 0.8,
      "evidence": "expression of PDE4A",
      "verified": true
    },
    {
      "id": "E9",
      "type": "Target",
      "name": "PDE4B",
      "attributes": {
        "target_type": "enzyme"
      },
      "source_chunk_ids": [
        "21a98f83de243122f2a63ceebb9ace2a"
      ],
      "confidence": 0.8,
      "evidence": "expression of PDE4B",
      "verified": true
    },
    {
      "id": "E10",
      "type": "Target",
      "name": "PDE4D",
      "attributes": {
        "target_type": "enzyme"
      },
      "source_chunk_ids": [
        "21a98f83de243122f2a63ceebb9ace2a"
      ],
      "confidence": 0.8,
      "evidence": "expression of PDE4D",
      "verified": true
    },
    {
      "id": "E11",
      "type": "Effect",
      "name": "enhance aspects of 5-HT-mediated neurotransmission",
      "attributes": {
        "level": "molecular",
        "valence": "positive"
      },
      "source_chunk_ids": [
        "21a98f83de243122f2a63ceebb9ace2a"
      ],
      "confidence": 0.7,
      "evidence": "PDE4 inhibitors enhance aspects",
      "verified": true
    },
    {
      "id": "E12",
      "type": "Effect",
      "name": "increase expression of PDE4A and PDE4B",
      "attributes": {
        "level": "cellular",
        "valence": "positive"
      },
      "source_chunk_ids": [
        "21a98f83de243122f2a63ceebb9ace2a"
      ],
      "confidence": 0.8,
      "evidence": "increases the expression of PDE4A and PDE4B",
      "verified": true
    },
    {
      "id": "E13",
      "type": "Effect",
      "name": "PDE4D activity affected by phosphorylation",
      "attributes": {
        "level": "molecular",
        "valence": "neutral"
      },
      "source_chunk_ids": [
        "21a98f83de243122f2a63ceebb9ace2a"
      ],
      "confidence": 0.75,
      "evidence": "PDE4D activity is particularly affected by phosphorylation",
      "verified": true
    },
    {
      "id": "E1",
      "type": "Target",
      "name": "PDE4",
      "attributes": {
        "target_type": "enzyme"
      },
      "source_chunk_ids": [
        "2ff9a599199735e9334bd4ffc2b41627"
      ],
      "confidence": 0.95,
      "evidence": "PDE4 is shown hydrolyzing cAMP",
      "verified": true
    },
    {
      "id": "E2",
      "type": "Target",
      "name": "NMDA receptor",
      "attributes": {
        "target_type": "receptor"
      },
      "source_chunk_ids": [
        "2ff9a599199735e9334bd4ffc2b41627"
      ],
      "confidence": 0.9,
      "evidence": "Glutamate binds to the NMDA receptor",
      "verified": true
    },
    {
      "id": "E3",
      "type": "Target",
      "name": "noradrenaline transporter",
      "attributes": {
        "target_type": "transporter"
      },
      "source_chunk_ids": [
        "2ff9a599199735e9334bd4ffc2b41627"
      ],
      "confidence": 0.9,
      "evidence": "Desipramine inhibits the noradrenaline transporter",
      "verified": true
    },
    {
      "id": "E4",
      "type": "Target",
      "name": "serotonin transporter",
      "attributes": {
        "target_type": "transporter"
      },
      "source_chunk_ids": [
        "2ff9a599199735e9334bd4ffc2b41627"
      ],
      "confidence": 0.9,
      "evidence": "Fluoxetine inhibits the serotonin transporter",
      "verified": true
    },
    {
      "id": "E5",
      "type": "Target",
      "name": "\u03b2-Adrenergic receptor",
      "attributes": {
        "target_type": "receptor"
      },
      "source_chunk_ids": [
        "2ff9a599199735e9334bd4ffc2b41627"
      ],
      "confidence": 0.85,
      "evidence": "\u03b2-Adrenergic receptor and 5-HT receptor",
      "verified": true
    },
    {
      "id": "E6",
      "type": "Target",
      "name": "5-HT receptor",
      "attributes": {
        "target_type": "receptor"
      },
      "source_chunk_ids": [
        "2ff9a599199735e9334bd4ffc2b41627"
      ],
      "confidence": 0.85,
      "evidence": "\u03b2-Adrenergic receptor and 5-HT receptor",
      "verified": true
    },
    {
      "id": "E7",
      "type": "Target",
      "name": "Adenylate Cyclase",
      "attributes": {
        "target_type": "enzyme"
      },
      "source_chunk_ids": [
        "2ff9a599199735e9334bd4ffc2b41627"
      ],
      "confidence": 0.8,
      "evidence": "activate Adenylate Cyclase (AC)",
      "verified": true
    },
    {
      "id": "E8",
      "type": "Target",
      "name": "PKA cascade",
      "attributes": {
        "target_type": "pathway"
      },
      "source_chunk_ids": [
        "2ff9a599199735e9334bd4ffc2b41627"
      ],
      "confidence": 0.8,
      "evidence": "cAMP activates the PKA cascade",
      "verified": true
    },
    {
      "id": "E9",
      "type": "Compound",
      "name": "Rolipram",
      "attributes": {},
      "source_chunk_ids": [
        "2ff9a599199735e9334bd4ffc2b41627"
      ],
      "confidence": 0.9,
      "evidence": "PDE4 is regulated by Rolipram",
      "verified": true
    },
    {
      "id": "E10",
      "type": "Effect",
      "name": "Antidepressant",
      "attributes": {
        "level": "behavioral",
        "valence": "positive"
      },
      "source_chunk_ids": [
        "2ff9a599199735e9334bd4ffc2b41627"
      ],
      "confidence": 0.85,
      "evidence": "PDE4A, PDE4B, and PDE4D interacting with Antidepressant",
      "verified": true
    },
    {
      "id": "E11",
      "type": "Effect",
      "name": "Memory enhancing",
      "attributes": {
        "level": "behavioral",
        "valence": "positive"
      },
      "source_chunk_ids": [
        "2ff9a599199735e9334bd4ffc2b41627"
      ],
      "confidence": 0.85,
      "evidence": "PDE4A, PDE4B, and PDE4D interacting with Memory enhancing",
      "verified": true
    },
    {
      "id": "E12",
      "type": "Effect",
      "name": "Emesis",
      "attributes": {
        "level": "systemic",
        "valence": "negative"
      },
      "source_chunk_ids": [
        "2ff9a599199735e9334bd4ffc2b41627"
      ],
      "confidence": 0.85,
      "evidence": "PDE4A, PDE4B, and PDE4D interacting with Emesis",
      "verified": true
    },
    {
      "id": "E13",
      "type": "Target",
      "name": "HARBS",
      "attributes": {
        "target_type": "binding site"
      },
      "source_chunk_ids": [
        "2ff9a599199735e9334bd4ffc2b41627"
      ],
      "confidence": 0.75,
      "evidence": "HARBS (High-affinity Rolipram-binding sites)",
      "verified": true
    },
    {
      "id": "E14",
      "type": "Target",
      "name": "LARBS",
      "attributes": {
        "target_type": "binding site"
      },
      "source_chunk_ids": [
        "2ff9a599199735e9334bd4ffc2b41627"
      ],
      "confidence": 0.75,
      "evidence": "LARBS (Low-affinity Rolipram-binding sites)",
      "verified": true
    },
    {
      "id": "E1",
      "type": "Target",
      "name": "PDE4",
      "attributes": {
        "target_type": "enzyme"
      },
      "source_chunk_ids": [
        "d1b266a586f21cad7004d900e58c7267"
      ],
      "confidence": 0.95,
      "evidence": "Type 4 phosphodiesterase (PDE4)",
      "verified": true
    },
    {
      "id": "E2",
      "type": "Target",
      "name": "beta-adrenergic receptor",
      "attributes": {
        "target_type": "receptor"
      },
      "source_chunk_ids": [
        "d1b266a586f21cad7004d900e58c7267"
      ],
      "confidence": 0.9,
      "evidence": "beta-adrenergic-receptor-mediated signaling",
      "verified": true
    },
    {
      "id": "E3",
      "type": "Target",
      "name": "NMDA receptor",
      "attributes": {
        "target_type": "receptor"
      },
      "source_chunk_ids": [
        "d1b266a586f21cad7004d900e58c7267"
      ],
      "confidence": 0.9,
      "evidence": "NMDA-receptor-mediated signaling",
      "verified": true
    },
    {
      "id": "E4",
      "type": "Target",
      "name": "5-HT receptor",
      "attributes": {
        "target_type": "receptor"
      },
      "source_chunk_ids": [
        "d1b266a586f21cad7004d900e58c7267"
      ],
      "confidence": 0.85,
      "evidence": "5-HT-receptor-mediated signaling",
      "verified": true
    },
    {
      "id": "E5",
      "type": "Target",
      "name": "RACK1",
      "attributes": {
        "target_type": "protein"
      },
      "source_chunk_ids": [
        "d1b266a586f21cad7004d900e58c7267"
      ],
      "confidence": 0.8,
      "evidence": "receptors for activated C kinases 1 (RACK1)",
      "verified": true
    },
    {
      "id": "E6",
      "type": "Target",
      "name": "AKAPs",
      "attributes": {
        "target_type": "protein"
      },
      "source_chunk_ids": [
        "d1b266a586f21cad7004d900e58c7267"
      ],
      "confidence": 0.8,
      "evidence": "A-kinase-anchoring proteins (AKAPs)",
      "verified": true
    },
    {
      "id": "E7",
      "type": "Target",
      "name": "NAT",
      "attributes": {
        "target_type": "transporter"
      },
      "source_chunk_ids": [
        "d1b266a586f21cad7004d900e58c7267"
      ],
      "confidence": 0.85,
      "evidence": "noradrenaline transporters (NATs)",
      "verified": true
    },
    {
      "id": "E8",
      "type": "Target",
      "name": "SERT",
      "attributes": {
        "target_type": "transporter"
      },
      "source_chunk_ids": [
        "d1b266a586f21cad7004d900e58c7267"
      ],
      "confidence": 0.85,
      "evidence": "5-HT transporters (SERTs)",
      "verified": true
    },
    {
      "id": "E9",
      "type": "Effect",
      "name": "increased cAMP-mediated signaling",
      "attributes": {
        "level": "molecular",
        "valence": "positive"
      },
      "source_chunk_ids": [
        "d1b266a586f21cad7004d900e58c7267"
      ],
      "confidence": 0.9,
      "evidence": "Inhibition of PDE4 increases cAMP-mediated signaling",
      "verified": true
    },
    {
      "id": "E10",
      "type": "Effect",
      "name": "antidepressant effect",
      "attributes": {
        "level": "behavioral",
        "valence": "positive"
      },
      "source_chunk_ids": [
        "d1b266a586f21cad7004d900e58c7267"
      ],
      "confidence": 0.85,
      "evidence": "antidepressant effects",
      "verified": true
    },
    {
      "id": "E11",
      "type": "Effect",
      "name": "memory-enhancing effect",
      "attributes": {
        "level": "behavioral",
        "valence": "positive"
      },
      "source_chunk_ids": [
        "d1b266a586f21cad7004d900e58c7267"
      ],
      "confidence": 0.85,
      "evidence": "memory-enhancing effects",
      "verified": true
    },
    {
      "id": "E12",
      "type": "Target",
      "name": "HARBS",
      "attributes": {
        "target_type": "binding site"
      },
      "source_chunk_ids": [
        "d1b266a586f21cad7004d900e58c7267"
      ],
      "confidence": 0.75,
      "evidence": "high-affinity rolipram-binding sites (HARBS)",
      "verified": true
    },
    {
      "id": "E13",
      "type": "Target",
      "name": "LARBS",
      "attributes": {
        "target_type": "binding site"
      },
      "source_chunk_ids": [
        "d1b266a586f21cad7004d900e58c7267"
      ],
      "confidence": 0.75,
      "evidence": "low-affinity rolipram-binding sites (LARBS)",
      "verified": true
    },
    {
      "id": "E1",
      "type": "Target",
      "name": "PDE4",
      "attributes": {
        "target_type": "enzyme"
      },
      "source_chunk_ids": [
        "8a565dbf31f1453b967c49a5c540a569"
      ],
      "confidence": 0.95,
      "evidence": "PDE4 is implicated in antidepressant actions",
      "verified": true
    },
    {
      "id": "E2",
      "type": "Target",
      "name": "NMDA receptors",
      "attributes": {
        "target_type": "receptor"
      },
      "source_chunk_ids": [
        "8a565dbf31f1453b967c49a5c540a569"
      ],
      "confidence": 0.95,
      "evidence": "NMDA-receptor-mediated signaling",
      "verified": true
    },
    {
      "id": "E3",
      "type": "Effect",
      "name": "antidepressant effects",
      "attributes": {
        "level": "behavioral",
        "valence": "positive"
      },
      "source_chunk_ids": [
        "8a565dbf31f1453b967c49a5c540a569"
      ],
      "confidence": 0.9,
      "evidence": "antidepressant actions",
      "verified": true
    },
    {
      "id": "E4",
      "type": "Effect",
      "name": "antidepressant-like effects on behavior",
      "attributes": {
        "level": "behavioral",
        "valence": "positive"
      },
      "source_chunk_ids": [
        "8a565dbf31f1453b967c49a5c540a569"
      ],
      "confidence": 0.85,
      "evidence": "produce antidepressant-like effects on behavior",
      "verified": true
    },
    {
      "id": "E5",
      "type": "Compound",
      "name": "MK801",
      "attributes": {},
      "source_chunk_ids": [
        "8a565dbf31f1453b967c49a5c540a569"
      ],
      "confidence": 0.9,
      "evidence": "MK801 (dizocilpine)",
      "verified": true
    },
    {
      "id": "E6",
      "type": "Compound",
      "name": "dizocilpine",
      "attributes": {},
      "source_chunk_ids": [
        "8a565dbf31f1453b967c49a5c540a569"
      ],
      "confidence": 0.9,
      "evidence": "MK801 (dizocilpine)",
      "verified": true
    },
    {
      "id": "E7",
      "type": "Compound",
      "name": "rolipram",
      "attributes": {},
      "source_chunk_ids": [
        "8a565dbf31f1453b967c49a5c540a569"
      ],
      "confidence": 0.9,
      "evidence": "rolipram has been shown",
      "verified": true
    },
    {
      "id": "E8",
      "type": "Effect",
      "name": "memory deficits",
      "attributes": {
        "level": "behavioral",
        "valence": "negative"
      },
      "source_chunk_ids": [
        "8a565dbf31f1453b967c49a5c540a569"
      ],
      "confidence": 0.85,
      "evidence": "reverse memory deficits",
      "verified": true
    },
    {
      "id": "E9",
      "type": "Condition",
      "name": "depression",
      "attributes": {
        "condition_type": "disorder"
      },
      "source_chunk_ids": [
        "8a565dbf31f1453b967c49a5c540a569"
      ],
      "confidence": 0.9,
      "evidence": "cognitive deficits that occur in depression",
      "verified": true
    },
    {
      "id": "E10",
      "type": "Effect",
      "name": "cognitive deficits",
      "attributes": {
        "level": "behavioral",
        "valence": "negative"
      },
      "source_chunk_ids": [
        "8a565dbf31f1453b967c49a5c540a569"
      ],
      "confidence": 0.8,
      "evidence": "cognitive deficits that occur in depression",
      "verified": true
    },
    {
      "id": "E11",
      "type": "Target",
      "name": "cAMP",
      "attributes": {
        "target_type": "molecule"
      },
      "source_chunk_ids": [
        "8a565dbf31f1453b967c49a5c540a569"
      ],
      "confidence": 0.85,
      "evidence": "increases intracellular concentrations of cAMP",
      "verified": true
    },
    {
      "id": "E12",
      "type": "Target",
      "name": "cGMP",
      "attributes": {
        "target_type": "molecule"
      },
      "source_chunk_ids": [
        "8a565dbf31f1453b967c49a5c540a569"
      ],
      "confidence": 0.85,
      "evidence": "increases intracellular concentrations of cGMP",
      "verified": true
    },
    {
      "id": "E13",
      "type": "Target",
      "name": "PDE2",
      "attributes": {
        "target_type": "enzyme"
      },
      "source_chunk_ids": [
        "8a565dbf31f1453b967c49a5c540a569"
      ],
      "confidence": 0.8,
      "evidence": "cGMP that forms is hydrolyzed by PDE2 only",
      "verified": true
    },
    {
      "id": "E1",
      "type": "CompoundClass",
      "name": "PDE4 inhibitors",
      "attributes": {},
      "source_chunk_ids": [
        "a9bf951806a526ce7d2abe85a7c1b07a"
      ],
      "confidence": 0.8,
      "evidence": "inhibitors of the PDE4 subtypes",
      "verified": true
    },
    {
      "id": "E2",
      "type": "Compound",
      "name": "rolipram",
      "attributes": {},
      "source_chunk_ids": [
        "a9bf951806a526ce7d2abe85a7c1b07a"
      ],
      "confidence": 0.9,
      "evidence": "rolipram",
      "verified": true
    },
    {
      "id": "E3",
      "type": "Compound",
      "name": "Ro201724",
      "attributes": {},
      "source_chunk_ids": [
        "a9bf951806a526ce7d2abe85a7c1b07a"
      ],
      "confidence": 0.9,
      "evidence": "Ro201724",
      "verified": true
    },
    {
      "id": "E4",
      "type": "Target",
      "name": "PDE4 subtypes",
      "attributes": {
        "target_type": "enzyme"
      },
      "source_chunk_ids": [
        "a9bf951806a526ce7d2abe85a7c1b07a"
      ],
      "confidence": 0.95,
      "evidence": "PDE4 subtypes",
      "verified": true
    },
    {
      "id": "E5",
      "type": "Target",
      "name": "PDE4B",
      "attributes": {
        "target_type": "enzyme"
      },
      "source_chunk_ids": [
        "a9bf951806a526ce7d2abe85a7c1b07a"
      ],
      "confidence": 0.85,
      "evidence": "PDE4B-knockout",
      "verified": true
    },
    {
      "id": "E6",
      "type": "Target",
      "name": "PDE4D",
      "attributes": {
        "target_type": "enzyme"
      },
      "source_chunk_ids": [
        "a9bf951806a526ce7d2abe85a7c1b07a"
      ],
      "confidence": 0.85,
      "evidence": "PDE4D-knockout",
      "verified": true
    },
    {
      "id": "E7",
      "type": "Effect",
      "name": "antidepressant effects",
      "attributes": {
        "level": "systemic",
        "valence": "positive"
      },
      "source_chunk_ids": [
        "a9bf951806a526ce7d2abe85a7c1b07a"
      ],
      "confidence": 0.9,
      "evidence": "antidepressant effects",
      "verified": true
    },
    {
      "id": "E8",
      "type": "Study",
      "name": "mouse knockout studies",
      "attributes": {
        "design": "knockout model"
      },
      "source_chunk_ids": [
        "a9bf951806a526ce7d2abe85a7c1b07a"
      ],
      "confidence": 0.75,
      "evidence": "mouse lines that are deficient",
      "verified": true
    },
    {
      "id": "E1",
      "type": "Target",
      "name": "PDE4D",
      "attributes": {
        "target_type": "enzyme"
      },
      "source_chunk_ids": [
        "5491df562c325ae25574b24b75a967aa"
      ],
      "confidence": 0.95,
      "evidence": "PDE4D-deficient mice",
      "verified": true
    },
    {
      "id": "E2",
      "type": "Effect",
      "name": "antidepressant-like profile",
      "attributes": {
        "level": "behavioral",
        "valence": "positive"
      },
      "source_chunk_ids": [
        "5491df562c325ae25574b24b75a967aa"
      ],
      "confidence": 0.9,
      "evidence": "antidepressant-like profile",
      "verified": true
    },
    {
      "id": "E3",
      "type": "Effect",
      "name": "reduced immobility",
      "attributes": {
        "level": "behavioral",
        "valence": "positive"
      },
      "source_chunk_ids": [
        "5491df562c325ae25574b24b75a967aa"
      ],
      "confidence": 0.95,
      "evidence": "reduced immobility",
      "verified": true
    },
    {
      "id": "E4",
      "type": "Compound",
      "name": "rolipram",
      "attributes": {},
      "source_chunk_ids": [
        "5491df562c325ae25574b24b75a967aa"
      ],
      "confidence": 0.95,
      "evidence": "rolipram",
      "verified": true
    },
    {
      "id": "E5",
      "type": "Compound",
      "name": "desipramine",
      "attributes": {},
      "source_chunk_ids": [
        "5491df562c325ae25574b24b75a967aa"
      ],
      "confidence": 0.9,
      "evidence": "desipramine",
      "verified": true
    },
    {
      "id": "E6",
      "type": "Compound",
      "name": "fluoxetine",
      "attributes": {},
      "source_chunk_ids": [
        "5491df562c325ae25574b24b75a967aa"
      ],
      "confidence": 0.9,
      "evidence": "fluoxetine",
      "verified": true
    },
    {
      "id": "E7",
      "type": "Study",
      "name": "PDE4D-deficient mice study",
      "attributes": {
        "design": "animal model study",
        "year": "implied from reference [43]"
      },
      "source_chunk_ids": [
        "5491df562c325ae25574b24b75a967aa"
      ],
      "confidence": 0.85,
      "evidence": "PDE4D-deficient mice exhibit",
      "verified": true
    },
    {
      "id": "E8",
      "type": "Evidence",
      "name": "in vivo animal evidence",
      "attributes": {
        "evidence_level": 2
      },
      "source_chunk_ids": [
        "5491df562c325ae25574b24b75a967aa"
      ],
      "confidence": 0.8,
      "evidence": "PDE4D-deficient mice exhibit",
      "verified": true
    },
    {
      "id": "E1",
      "type": "Compound",
      "name": "rolipram",
      "attributes": {},
      "source_chunk_ids": [
        "3fcaa03a54b2f6cedb9f791441394f66"
      ],
      "confidence": 0.95,
      "evidence": "rolipram",
      "verified": true
    },
    {
      "id": "E2",
      "type": "Target",
      "name": "PDE4D",
      "attributes": {
        "target_type": "enzyme"
      },
      "source_chunk_ids": [
        "3fcaa03a54b2f6cedb9f791441394f66"
      ],
      "confidence": 0.9,
      "evidence": "PDE4D-deficient mice",
      "verified": true
    },
    {
      "id": "E3",
      "type": "Target",
      "name": "beta-adrenoceptor",
      "attributes": {
        "target_type": "receptor"
      },
      "source_chunk_ids": [
        "3fcaa03a54b2f6cedb9f791441394f66"
      ],
      "confidence": 0.85,
      "evidence": "beta-adrenoceptor-mediated cAMP formation",
      "verified": true
    },
    {
      "id": "E4",
      "type": "Compound",
      "name": "desipramine",
      "attributes": {},
      "source_chunk_ids": [
        "3fcaa03a54b2f6cedb9f791441394f66"
      ],
      "confidence": 0.95,
      "evidence": "desipramine",
      "verified": true
    },
    {
      "id": "E5",
      "type": "Compound",
      "name": "fluoxetine",
      "attributes": {},
      "source_chunk_ids": [
        "3fcaa03a54b2f6cedb9f791441394f66"
      ],
      "confidence": 0.95,
      "evidence": "fluoxetine",
      "verified": true
    },
    {
      "id": "E6",
      "type": "Effect",
      "name": "enhanced cAMP formation",
      "attributes": {
        "level": "molecular",
        "valence": "positive"
      },
      "source_chunk_ids": [
        "3fcaa03a54b2f6cedb9f791441394f66"
      ],
      "confidence": 0.8,
      "evidence": "enhance beta-adrenoceptor-mediated cAMP formation",
      "verified": true
    },
    {
      "id": "E7",
      "type": "Effect",
      "name": "diminished cAMP formation enhancement",
      "attributes": {
        "level": "molecular",
        "valence": "negative"
      },
      "source_chunk_ids": [
        "3fcaa03a54b2f6cedb9f791441394f66"
      ],
      "confidence": 0.75,
      "evidence": "diminished in PDE4D-deficient mice",
      "verified": true
    },
    {
      "id": "E8",
      "type": "Effect",
      "name": "increased receptor-mediated cAMP formation",
      "attributes": {
        "level": "molecular",
        "valence": "positive"
      },
      "source_chunk_ids": [
        "3fcaa03a54b2f6cedb9f791441394f66"
      ],
      "confidence": 0.7,
      "evidence": "increasing receptor-mediated cAMP formation",
      "verified": true
    },
    {
      "id": "E9",
      "type": "Effect",
      "name": "enhanced drug effects",
      "attributes": {
        "level": "systemic",
        "valence": "positive",
        "verification_needed": true
      },
      "source_chunk_ids": [
        "3fcaa03a54b2f6cedb9f791441394f66"
      ],
      "confidence": 0.65,
      "evidence": "enhance the effects of desipramine and fluoxetine",
      "verified": false
    },
    {
      "id": "E10",
      "type": "Effect",
      "name": "increased drug potency",
      "attributes": {
        "level": "systemic",
        "valence": "positive",
        "verification_needed": true
      },
      "source_chunk_ids": [
        "3fcaa03a54b2f6cedb9f791441394f66"
      ],
      "confidence": 0.65,
      "evidence": "increase the potency of these drugs",
      "verified": false
    },
    {
      "id": "E1",
      "type": "Target",
      "name": "PDE4B",
      "attributes": {
        "target_type": "enzyme"
      },
      "source_chunk_ids": [
        "71a1953f84ad5fcc11d2125c2c179e00"
      ],
      "confidence": 0.9,
      "evidence": "PDE4B subtype",
      "verified": true
    },
    {
      "id": "E2",
      "type": "Target",
      "name": "PDE4D",
      "attributes": {
        "target_type": "enzyme"
      },
      "source_chunk_ids": [
        "71a1953f84ad5fcc11d2125c2c179e00"
      ],
      "confidence": 0.9,
      "evidence": "PDE4D-deficient mice",
      "verified": true
    },
    {
      "id": "E3",
      "type": "Effect",
      "name": "antidepressant-like profile",
      "attributes": {
        "level": "behavioral",
        "valence": "positive"
      },
      "source_chunk_ids": [
        "71a1953f84ad5fcc11d2125c2c179e00"
      ],
      "confidence": 0.85,
      "evidence": "antidepressant-like profile",
      "verified": true
    },
    {
      "id": "E4",
      "type": "Compound",
      "name": "rolipram",
      "attributes": {},
      "source_chunk_ids": [
        "71a1953f84ad5fcc11d2125c2c179e00"
      ],
      "confidence": 0.95,
      "evidence": "rolipram",
      "verified": true
    },
    {
      "id": "E5",
      "type": "Compound",
      "name": "desipramine",
      "attributes": {},
      "source_chunk_ids": [
        "71a1953f84ad5fcc11d2125c2c179e00"
      ],
      "confidence": 0.95,
      "evidence": "desipramine",
      "verified": true
    },
    {
      "id": "E6",
      "type": "Target",
      "name": "5-HT-reuptake inhibitors",
      "attributes": {
        "target_type": "transporter"
      },
      "source_chunk_ids": [
        "71a1953f84ad5fcc11d2125c2c179e00"
      ],
      "confidence": 0.8,
      "evidence": "5-HT-reuptake inhibitors",
      "verified": true
    },
    {
      "id": "E7",
      "type": "Study",
      "name": "Zhang and O'Donnell unpublished",
      "attributes": {
        "design": "preliminary results",
        "year": "unpublished"
      },
      "source_chunk_ids": [
        "71a1953f84ad5fcc11d2125c2c179e00"
      ],
      "confidence": 0.7,
      "evidence": "H.-T. Zhang and J.M. O'Donnell, unpublished",
      "verified": true
    },
    {
      "id": "E8",
      "type": "Evidence",
      "name": "in vivo",
      "attributes": {
        "evidence_level": 2
      },
      "source_chunk_ids": [
        "71a1953f84ad5fcc11d2125c2c179e00"
      ],
      "confidence": 0.75,
      "evidence": "PDE4B-deficient mice",
      "verified": true
    },
    {
      "id": "E1",
      "type": "Target",
      "name": "PDE4D",
      "attributes": {
        "target_type": "enzyme"
      },
      "source_chunk_ids": [
        "61fda0e6683450b82c7a2d8f19d254d5"
      ],
      "confidence": 0.95,
      "evidence": "PDE4D subtype",
      "verified": true
    },
    {
      "id": "E2",
      "type": "Target",
      "name": "PDE4A",
      "attributes": {
        "target_type": "enzyme"
      },
      "source_chunk_ids": [
        "61fda0e6683450b82c7a2d8f19d254d5"
      ],
      "confidence": 0.9,
      "evidence": "PDE4A-deficient mice",
      "verified": true
    },
    {
      "id": "E3",
      "type": "Target",
      "name": "PDE4B",
      "attributes": {
        "target_type": "enzyme"
      },
      "source_chunk_ids": [
        "61fda0e6683450b82c7a2d8f19d254d5"
      ],
      "confidence": 0.9,
      "evidence": "PDE4A and PDE4B",
      "verified": true
    },
    {
      "id": "E4",
      "type": "Effect",
      "name": "antidepressant-like effects",
      "attributes": {
        "level": "behavioral",
        "valence": "positive"
      },
      "source_chunk_ids": [
        "61fda0e6683450b82c7a2d8f19d254d5"
      ],
      "confidence": 0.85,
      "evidence": "antidepressant-like effects",
      "verified": true
    },
    {
      "id": "E5",
      "type": "AdverseEvent",
      "name": "emesis",
      "attributes": {
        "severity": "not specified"
      },
      "source_chunk_ids": [
        "61fda0e6683450b82c7a2d8f19d254d5"
      ],
      "confidence": 0.9,
      "evidence": "side-effects of emesis",
      "verified": true
    },
    {
      "id": "E6",
      "type": "AdverseEvent",
      "name": "sedation",
      "attributes": {
        "severity": "not specified"
      },
      "source_chunk_ids": [
        "61fda0e6683450b82c7a2d8f19d254d5"
      ],
      "confidence": 0.9,
      "evidence": "side-effects of ... sedation",
      "verified": true
    },
    {
      "id": "E7",
      "type": "CompoundClass",
      "name": "PDE4 inhibitors",
      "attributes": {},
      "source_chunk_ids": [
        "61fda0e6683450b82c7a2d8f19d254d5"
      ],
      "confidence": 0.95,
      "evidence": "PDE4 inhibitors",
      "verified": true
    },
    {
      "id": "E8",
      "type": "Condition",
      "name": "depression",
      "attributes": {
        "condition_type": "disease"
      },
      "source_chunk_ids": [
        "61fda0e6683450b82c7a2d8f19d254d5"
      ],
      "confidence": 0.8,
      "evidence": "antidepressant-like effects",
      "verified": true
    },
    {
      "id": "E1",
      "type": "Target",
      "name": "PDE4",
      "attributes": {
        "target_type": "enzyme"
      },
      "source_chunk_ids": [
        "caf80bdf725c1fa6209c0c2d12006214"
      ],
      "confidence": 0.9,
      "evidence": "PDE4 inhibitors",
      "verified": true
    },
    {
      "id": "E2",
      "type": "Compound",
      "name": "rolipram",
      "attributes": {},
      "source_chunk_ids": [
        "caf80bdf725c1fa6209c0c2d12006214"
      ],
      "confidence": 0.95,
      "evidence": "rolipram binding",
      "verified": true
    },
    {
      "id": "E3",
      "type": "Target",
      "name": "HARBS",
      "attributes": {
        "target_type": "binding conformer"
      },
      "source_chunk_ids": [
        "caf80bdf725c1fa6209c0c2d12006214"
      ],
      "confidence": 0.8,
      "evidence": "high-affinity binding conformers (the HARBS)",
      "verified": true
    },
    {
      "id": "E4",
      "type": "Target",
      "name": "LARBS",
      "attributes": {
        "target_type": "binding conformer"
      },
      "source_chunk_ids": [
        "caf80bdf725c1fa6209c0c2d12006214"
      ],
      "confidence": 0.8,
      "evidence": "low-affinity binding conformers (the LARBS)",
      "verified": true
    },
    {
      "id": "E5",
      "type": "Evidence",
      "name": "in vitro binding study",
      "attributes": {
        "evidence_level": 2
      },
      "source_chunk_ids": [
        "caf80bdf725c1fa6209c0c2d12006214"
      ],
      "confidence": 0.7,
      "evidence": "binding to brain membranes",
      "verified": true
    },
    {
      "id": "E1",
      "type": "Target",
      "name": "PDE4A",
      "attributes": {
        "target_type": "enzyme"
      },
      "source_chunk_ids": [
        "50093827e7a3ffc2e25a0d18067a5338"
      ],
      "confidence": 0.9,
      "evidence": "recombinant PDE4A",
      "verified": true
    },
    {
      "id": "E2",
      "type": "Compound",
      "name": "rolipram",
      "attributes": {},
      "source_chunk_ids": [
        "50093827e7a3ffc2e25a0d18067a5338"
      ],
      "confidence": 0.95,
      "evidence": "rolipram binds",
      "verified": true
    },
    {
      "id": "E3",
      "type": "Compound",
      "name": "piclamilast",
      "attributes": {},
      "source_chunk_ids": [
        "50093827e7a3ffc2e25a0d18067a5338"
      ],
      "confidence": 0.85,
      "evidence": "piclamilast",
      "verified": true
    },
    {
      "id": "E4",
      "type": "Evidence",
      "name": "in vitro",
      "attributes": {
        "evidence_level": 2
      },
      "source_chunk_ids": [
        "50093827e7a3ffc2e25a0d18067a5338"
      ],
      "confidence": 0.7,
      "evidence": "technique that assesses interactions",
      "verified": true
    },
    {
      "id": "E1",
      "type": "Compound",
      "name": "rolipram",
      "attributes": {},
      "source_chunk_ids": [
        "80eabf32513520a8d886aeb8c856efb4"
      ],
      "confidence": 0.95,
      "evidence": "high-affinity and low-affinity binding sites for rolipram",
      "verified": true
    },
    {
      "id": "E2",
      "type": "Target",
      "name": "HARBS",
      "attributes": {
        "target_type": "binding site"
      },
      "source_chunk_ids": [
        "80eabf32513520a8d886aeb8c856efb4"
      ],
      "confidence": 0.85,
      "evidence": "affinity for the HARBS",
      "verified": true
    },
    {
      "id": "E3",
      "type": "Target",
      "name": "LARBS",
      "attributes": {
        "target_type": "binding site"
      },
      "source_chunk_ids": [
        "80eabf32513520a8d886aeb8c856efb4"
      ],
      "confidence": 0.85,
      "evidence": "more closely related to the LARBS",
      "verified": true
    },
    {
      "id": "E4",
      "type": "Effect",
      "name": "induction of head twitches and tremor in mice",
      "attributes": {
        "level": "behavioral",
        "valence": "negative"
      },
      "source_chunk_ids": [
        "80eabf32513520a8d886aeb8c856efb4"
      ],
      "confidence": 0.8,
      "evidence": "induction of head twitches and tremor in mice",
      "verified": true
    },
    {
      "id": "E5",
      "type": "Effect",
      "name": "emesis in ferrets",
      "attributes": {
        "level": "systemic",
        "valence": "negative"
      },
      "source_chunk_ids": [
        "80eabf32513520a8d886aeb8c856efb4"
      ],
      "confidence": 0.8,
      "evidence": "emesis in ferrets",
      "verified": true
    },
    {
      "id": "E6",
      "type": "Effect",
      "name": "inhibition of mast cell degranulation",
      "attributes": {
        "level": "cellular",
        "valence": "negative"
      },
      "source_chunk_ids": [
        "80eabf32513520a8d886aeb8c856efb4"
      ],
      "confidence": 0.8,
      "evidence": "inhibition of mast cell degranulation",
      "verified": true
    },
    {
      "id": "E7",
      "type": "Effect",
      "name": "inhibition of antigen-induced T-cell proliferation in guinea-pigs",
      "attributes": {
        "level": "cellular",
        "valence": "negative"
      },
      "source_chunk_ids": [
        "80eabf32513520a8d886aeb8c856efb4"
      ],
      "confidence": 0.8,
      "evidence": "inhibition of antigen-induced T-cell proliferation in guinea-pigs",
      "verified": true
    },
    {
      "id": "E1",
      "type": "Target",
      "name": "HARBS",
      "attributes": {
        "target_type": "binding site"
      },
      "source_chunk_ids": [
        "bd5729556bfa08457465c1c27eaa40af"
      ],
      "confidence": 0.9,
      "evidence": "HARBS appears to be present in brain",
      "verified": true
    },
    {
      "id": "E2",
      "type": "Target",
      "name": "PDE4",
      "attributes": {
        "target_type": "enzyme"
      },
      "source_chunk_ids": [
        "bd5729556bfa08457465c1c27eaa40af"
      ],
      "confidence": 0.95,
      "evidence": "PDE4 is expressed throughout the body",
      "verified": true
    },
    {
      "id": "E3",
      "type": "Target",
      "name": "A-kinase-anchoring proteins",
      "attributes": {
        "target_type": "protein"
      },
      "source_chunk_ids": [
        "bd5729556bfa08457465c1c27eaa40af"
      ],
      "confidence": 0.8,
      "evidence": "proteins such as A-kinase-anchoring proteins",
      "verified": true
    },
    {
      "id": "E4",
      "type": "Target",
      "name": "RACK1",
      "attributes": {
        "target_type": "protein"
      },
      "source_chunk_ids": [
        "bd5729556bfa08457465c1c27eaa40af"
      ],
      "confidence": 0.8,
      "evidence": "receptors for activated C kinases 1 (RACK1)",
      "verified": true
    },
    {
      "id": "E5",
      "type": "Target",
      "name": "SH3 domain proteins",
      "attributes": {
        "target_type": "protein"
      },
      "source_chunk_ids": [
        "bd5729556bfa08457465c1c27eaa40af"
      ],
      "confidence": 0.75,
      "evidence": "proteins that contain SH3 domains",
      "verified": true
    },
    {
      "id": "E6",
      "type": "Effect",
      "name": "reducing immobility in forced-swim test",
      "attributes": {
        "level": "behavioral",
        "valence": "positive"
      },
      "source_chunk_ids": [
        "bd5729556bfa08457465c1c27eaa40af"
      ],
      "confidence": 0.85,
      "evidence": "reducing immobility of mice in the forced-swim test",
      "verified": true
    },
    {
      "id": "E7",
      "type": "Effect",
      "name": "CNS effects of PDE4 inhibitors",
      "attributes": {
        "level": "systemic",
        "valence": "positive"
      },
      "source_chunk_ids": [
        "bd5729556bfa08457465c1c27eaa40af"
      ],
      "confidence": 0.8,
      "evidence": "CNS effects of PDE4 inhibitors",
      "verified": true
    },
    {
      "id": "E8",
      "type": "Study",
      "name": "Saccomano et al. (unpublished)",
      "attributes": {
        "design": "experimental study",
        "year": "unpublished"
      },
      "source_chunk_ids": [
        "bd5729556bfa08457465c1c27eaa40af"
      ],
      "confidence": 0.7,
      "evidence": "Saccomano and co-workers [16] found",
      "verified": true
    },
    {
      "id": "E9",
      "type": "Evidence",
      "name": "in vitro binding assay",
      "attributes": {
        "evidence_level": 2
      },
      "source_chunk_ids": [
        "bd5729556bfa08457465c1c27eaa40af"
      ],
      "confidence": 0.75,
      "evidence": "inhibition of [^{3}H]-rolipram binding",
      "verified": true
    },
    {
      "id": "E10",
      "type": "Evidence",
      "name": "animal behavioral test",
      "attributes": {
        "evidence_level": 3
      },
      "source_chunk_ids": [
        "bd5729556bfa08457465c1c27eaa40af"
      ],
      "confidence": 0.8,
      "evidence": "forced-swim test in rats",
      "verified": true
    },
    {
      "id": "E1",
      "type": "Compound",
      "name": "desipramine",
      "attributes": {},
      "source_chunk_ids": [
        "75b2c2fb00b45bdaa16e7d05ef8076c8"
      ],
      "confidence": 0.9,
      "evidence": "desipramine",
      "verified": true
    },
    {
      "id": "E2",
      "type": "Compound",
      "name": "fluoxetine",
      "attributes": {},
      "source_chunk_ids": [
        "75b2c2fb00b45bdaa16e7d05ef8076c8"
      ],
      "confidence": 0.9,
      "evidence": "fluoxetine",
      "verified": true
    },
    {
      "id": "E3",
      "type": "Target",
      "name": "noradrenaline-mediated neurotransmission",
      "attributes": {
        "target_type": "neurotransmission"
      },
      "source_chunk_ids": [
        "75b2c2fb00b45bdaa16e7d05ef8076c8"
      ],
      "confidence": 0.8,
      "evidence": "noradrenaline-mediated actions",
      "verified": true
    },
    {
      "id": "E4",
      "type": "Target",
      "name": "5-HT-mediated neurotransmission",
      "attributes": {
        "target_type": "neurotransmission"
      },
      "source_chunk_ids": [
        "75b2c2fb00b45bdaa16e7d05ef8076c8"
      ],
      "confidence": 0.8,
      "evidence": "5-HT-mediated actions",
      "verified": true
    },
    {
      "id": "E5",
      "type": "Target",
      "name": "PDE4",
      "attributes": {
        "target_type": "enzyme"
      },
      "source_chunk_ids": [
        "75b2c2fb00b45bdaa16e7d05ef8076c8"
      ],
      "confidence": 0.85,
      "evidence": "PDE4",
      "verified": true
    },
    {
      "id": "E6",
      "type": "Effect",
      "name": "increase in HARBS binding",
      "attributes": {
        "level": "molecular",
        "valence": "positive"
      },
      "source_chunk_ids": [
        "75b2c2fb00b45bdaa16e7d05ef8076c8"
      ],
      "confidence": 0.75,
      "evidence": "increases the HARBS",
      "verified": true
    },
    {
      "id": "E7",
      "type": "Effect",
      "name": "no increase in LARBS binding",
      "attributes": {
        "level": "molecular",
        "valence": "neutral"
      },
      "source_chunk_ids": [
        "75b2c2fb00b45bdaa16e7d05ef8076c8"
      ],
      "confidence": 0.75,
      "evidence": "not the LARBS",
      "verified": true
    },
    {
      "id": "E8",
      "type": "Effect",
      "name": "antidepressant effects",
      "attributes": {
        "level": "systemic",
        "valence": "positive"
      },
      "source_chunk_ids": [
        "75b2c2fb00b45bdaa16e7d05ef8076c8"
      ],
      "confidence": 0.8,
      "evidence": "antidepressant effects",
      "verified": true
    },
    {
      "id": "E1",
      "type": "Target",
      "name": "PDE4",
      "attributes": {
        "target_type": "enzyme"
      },
      "source_chunk_ids": [
        "fa409341bf8245f30b66ff1e73ef0e25"
      ],
      "confidence": 0.9,
      "evidence": "PDE4 is the predominant PDE",
      "verified": true
    },
    {
      "id": "E2",
      "type": "Target",
      "name": "\u03b2-adrenoceptor-linked adenylyl cyclase pathway",
      "attributes": {
        "target_type": "pathway"
      },
      "source_chunk_ids": [
        "fa409341bf8245f30b66ff1e73ef0e25"
      ],
      "confidence": 0.8,
      "evidence": "\u03b2-adrenoceptor-linked adenylyl cyclase pathway",
      "verified": true
    },
    {
      "id": "E3",
      "type": "Target",
      "name": "5-HT-receptor-mediated signaling",
      "attributes": {
        "target_type": "pathway"
      },
      "source_chunk_ids": [
        "fa409341bf8245f30b66ff1e73ef0e25"
      ],
      "confidence": 0.8,
      "evidence": "5-HT-receptor-mediated signaling",
      "verified": true
    },
    {
      "id": "E4",
      "type": "Condition",
      "name": "depression",
      "attributes": {
        "condition_type": "disease"
      },
      "source_chunk_ids": [
        "fa409341bf8245f30b66ff1e73ef0e25"
      ],
      "confidence": 0.7,
      "evidence": "signaling pathways that are affected by antidepressants",
      "verified": true
    },
    {
      "id": "E1",
      "type": "Target",
      "name": "PDE4",
      "attributes": {
        "target_type": "enzyme"
      },
      "source_chunk_ids": [
        "48c14a07868915458502117c76e8d780"
      ],
      "confidence": 0.9,
      "evidence": "PDE4 inhibitors",
      "verified": true
    },
    {
      "id": "E2",
      "type": "Target",
      "name": "HARBS",
      "attributes": {
        "target_type": "binding conformer"
      },
      "source_chunk_ids": [
        "48c14a07868915458502117c76e8d780"
      ],
      "confidence": 0.85,
      "evidence": "high-affinity binding conformers (HARBS)",
      "verified": true
    },
    {
      "id": "E3",
      "type": "Target",
      "name": "LARBS",
      "attributes": {
        "target_type": "binding conformer"
      },
      "source_chunk_ids": [
        "48c14a07868915458502117c76e8d780"
      ],
      "confidence": 0.85,
      "evidence": "low-affinity binding conformers (LARBS)",
      "verified": true
    },
    {
      "id": "E4",
      "type": "Effect",
      "name": "alter cAMP hydrolysis",
      "attributes": {
        "level": "molecular",
        "valence": "neutral"
      },
      "source_chunk_ids": [
        "48c14a07868915458502117c76e8d780"
      ],
      "confidence": 0.8,
      "evidence": "alter cAMP hydrolysis",
      "verified": true
    },
    {
      "id": "E5",
      "type": "Effect",
      "name": "alter PDE4-related CNS function",
      "attributes": {
        "level": "systemic",
        "valence": "neutral"
      },
      "source_chunk_ids": [
        "48c14a07868915458502117c76e8d780"
      ],
      "confidence": 0.8,
      "evidence": "alter PDE4-related CNS function",
      "verified": true
    },
    {
      "id": "E6",
      "type": "Condition",
      "name": "depression",
      "attributes": {
        "condition_type": "disorder"
      },
      "source_chunk_ids": [
        "48c14a07868915458502117c76e8d780"
      ],
      "confidence": 0.75,
      "evidence": "mediation of antidepressant activity",
      "verified": true
    },
    {
      "id": "E1",
      "type": "Compound",
      "name": "rolipram",
      "attributes": {},
      "source_chunk_ids": [
        "8a033d3d806294e79fa7a7bf320bafad"
      ],
      "confidence": 0.95,
      "evidence": "rolipram and other selective adenosine cyclic 3',5'-monophosphate phosphodiesterase inhibitors",
      "verified": true
    },
    {
      "id": "E2",
      "type": "Target",
      "name": "cAMP phosphodiesterase",
      "attributes": {
        "target_type": "enzyme"
      },
      "source_chunk_ids": [
        "8a033d3d806294e79fa7a7bf320bafad"
      ],
      "confidence": 0.9,
      "evidence": "selective adenosine cyclic 3',5'-monophosphate phosphodiesterase inhibitors",
      "verified": true
    },
    {
      "id": "E3",
      "type": "Effect",
      "name": "behavioral alterations",
      "attributes": {
        "level": "behavioral",
        "valence": "neutral"
      },
      "source_chunk_ids": [
        "8a033d3d806294e79fa7a7bf320bafad"
      ],
      "confidence": 0.8,
      "evidence": "Characteristic behavioral alterations in rats induced by rolipram",
      "verified": true
    },
    {
      "id": "E4",
      "type": "Effect",
      "name": "antidepressant activity",
      "attributes": {
        "level": "behavioral",
        "valence": "positive"
      },
      "source_chunk_ids": [
        "8a033d3d806294e79fa7a7bf320bafad"
      ],
      "confidence": 0.85,
      "evidence": "Potential antidepressant activity of rolipram",
      "verified": true
    },
    {
      "id": "E5",
      "type": "Study",
      "name": "Wachtel 1982",
      "attributes": {
        "year": 1982
      },
      "source_chunk_ids": [
        "8a033d3d806294e79fa7a7bf320bafad"
      ],
      "confidence": 0.9,
      "evidence": "Wachtel, H. (1982) Characteristic behavioral alterations in rats induced by rolipram",
      "verified": true
    },
    {
      "id": "E6",
      "type": "Study",
      "name": "Wachtel 1983",
      "attributes": {
        "year": 1983
      },
      "source_chunk_ids": [
        "8a033d3d806294e79fa7a7bf320bafad"
      ],
      "confidence": 0.9,
      "evidence": "Wachtel, H. (1983) Potential antidepressant activity of rolipram",
      "verified": true
    },
    {
      "id": "E7",
      "type": "Study",
      "name": "Zeller 1984",
      "attributes": {
        "year": 1984
      },
      "source_chunk_ids": [
        "8a033d3d806294e79fa7a7bf320bafad"
      ],
      "confidence": 0.9,
      "evidence": "Zeller, E. (1984) Results of a phase II study of the antidepressant effect of rolipram",
      "verified": true
    },
    {
      "id": "E8",
      "type": "Evidence",
      "name": "in vitro",
      "attributes": {
        "evidence_level": 2
      },
      "source_chunk_ids": [
        "8a033d3d806294e79fa7a7bf320bafad"
      ],
      "confidence": 0.8,
      "evidence": "in vitro studies mentioned",
      "verified": true
    },
    {
      "id": "E9",
      "type": "Evidence",
      "name": "clinical trial",
      "attributes": {
        "evidence_level": 4
      },
      "source_chunk_ids": [
        "8a033d3d806294e79fa7a7bf320bafad"
      ],
      "confidence": 0.85,
      "evidence": "phase II study of the antidepressant effect of rolipram",
      "verified": true
    },
    {
      "id": "E10",
      "type": "Condition",
      "name": "depression",
      "attributes": {
        "condition_type": "disorder"
      },
      "source_chunk_ids": [
        "8a033d3d806294e79fa7a7bf320bafad"
      ],
      "confidence": 0.9,
      "evidence": "antidepressant effect of rolipram",
      "verified": true
    },
    {
      "id": "E11",
      "type": "AdverseEvent",
      "name": "emesis",
      "attributes": {
        "severity": "not specified"
      },
      "source_chunk_ids": [
        "8a033d3d806294e79fa7a7bf320bafad"
      ],
      "confidence": 0.8,
      "evidence": "Emesis induced by inhibitors of type IV cyclic nucleotide phosphodiesterase",
      "verified": true
    },
    {
      "id": "E12",
      "type": "Effect",
      "name": "sedative effects",
      "attributes": {
        "level": "behavioral",
        "valence": "negative"
      },
      "source_chunk_ids": [
        "8a033d3d806294e79fa7a7bf320bafad"
      ],
      "confidence": 0.75,
      "evidence": "sedative effects of rolipram in rats",
      "verified": true
    },
    {
      "id": "E1",
      "type": "Target",
      "name": "PDE4",
      "attributes": {
        "target_type": "enzyme"
      },
      "source_chunk_ids": [
        "387a41515771a03ed7e7cdefcf4c33ff"
      ],
      "confidence": 0.9,
      "evidence": "cyclic AMP phosphodiesterase (PDE4)",
      "verified": true
    },
    {
      "id": "E2",
      "type": "Target",
      "name": "PDE4A",
      "attributes": {
        "target_type": "enzyme"
      },
      "source_chunk_ids": [
        "387a41515771a03ed7e7cdefcf4c33ff"
      ],
      "confidence": 0.85,
      "evidence": "cAMP-specific phosphodiesterase 4A",
      "verified": true
    },
    {
      "id": "E3",
      "type": "Target",
      "name": "PDE4B",
      "attributes": {
        "target_type": "enzyme"
      },
      "source_chunk_ids": [
        "387a41515771a03ed7e7cdefcf4c33ff"
      ],
      "confidence": 0.85,
      "evidence": "cAMP-specific phosphodiesterase 4B",
      "verified": true
    },
    {
      "id": "E4",
      "type": "Target",
      "name": "PDE4D",
      "attributes": {
        "target_type": "enzyme"
      },
      "source_chunk_ids": [
        "387a41515771a03ed7e7cdefcf4c33ff"
      ],
      "confidence": 0.85,
      "evidence": "phosphodiesterase 4D",
      "verified": true
    },
    {
      "id": "E5",
      "type": "Target",
      "name": "NMDA receptor",
      "attributes": {
        "target_type": "receptor"
      },
      "source_chunk_ids": [
        "387a41515771a03ed7e7cdefcf4c33ff"
      ],
      "confidence": 0.9,
      "evidence": "NMDA receptor",
      "verified": true
    },
    {
      "id": "E6",
      "type": "Condition",
      "name": "depression",
      "attributes": {
        "condition_type": "disorder"
      },
      "source_chunk_ids": [
        "387a41515771a03ed7e7cdefcf4c33ff"
      ],
      "confidence": 0.8,
      "evidence": "antidepressant actions",
      "verified": true
    },
    {
      "id": "E7",
      "type": "Condition",
      "name": "memory deficits",
      "attributes": {
        "condition_type": "symptom"
      },
      "source_chunk_ids": [
        "387a41515771a03ed7e7cdefcf4c33ff"
      ],
      "confidence": 0.75,
      "evidence": "memory deficits",
      "verified": true
    },
    {
      "id": "E8",
      "type": "Effect",
      "name": "antidepressant-like effect",
      "attributes": {
        "level": "behavioral",
        "valence": "positive"
      },
      "source_chunk_ids": [
        "387a41515771a03ed7e7cdefcf4c33ff"
      ],
      "confidence": 0.7,
      "evidence": "Antidepressant-like profile",
      "verified": true
    },
    {
      "id": "E9",
      "type": "Study",
      "name": "Zhang et al. (2000)",
      "attributes": {
        "year": 2000
      },
      "source_chunk_ids": [
        "387a41515771a03ed7e7cdefcf4c33ff"
      ],
      "confidence": 0.8,
      "evidence": "Zhang, H.T. et al. (2000)",
      "verified": true
    },
    {
      "id": "E10",
      "type": "Study",
      "name": "Zhang et al. (2002)",
      "attributes": {
        "year": 2002
      },
      "source_chunk_ids": [
        "387a41515771a03ed7e7cdefcf4c33ff"
      ],
      "confidence": 0.8,
      "evidence": "Zhang, H.T. et al. (2002)",
      "verified": true
    },
    {
      "id": "E11",
      "type": "Evidence",
      "name": "in vitro",
      "attributes": {
        "evidence_level": 2
      },
      "source_chunk_ids": [
        "387a41515771a03ed7e7cdefcf4c33ff"
      ],
      "confidence": 0.7,
      "evidence": "in vitro",
      "verified": true
    },
    {
      "id": "E12",
      "type": "Evidence",
      "name": "animal study",
      "attributes": {
        "evidence_level": 3
      },
      "source_chunk_ids": [
        "387a41515771a03ed7e7cdefcf4c33ff"
      ],
      "confidence": 0.7,
      "evidence": "mice deficient",
      "verified": true
    }
  ],
  "relationships": [
    {
      "id": "R1",
      "type": "ACTS_ON",
      "source_entity_id": "E1",
      "target_entity_id": "E5",
      "attributes": {
        "action": "involved in"
      },
      "confidence": 0.75,
      "evidence": "PDE4 has been shown to be involved in cAMP signaling pathways",
      "source_chunk_ids": [
        "965d5e31ae90be5dca185dacd7b62c07"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R2",
      "type": "PRODUCES",
      "source_entity_id": "E3",
      "target_entity_id": "E7",
      "attributes": {},
      "confidence": 0.7,
      "evidence": "PDE4D and PDE4B mediate antidepressant effects",
      "source_chunk_ids": [
        "965d5e31ae90be5dca185dacd7b62c07"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R3",
      "type": "PRODUCES",
      "source_entity_id": "E4",
      "target_entity_id": "E7",
      "attributes": {},
      "confidence": 0.7,
      "evidence": "PDE4D and PDE4B mediate antidepressant effects",
      "source_chunk_ids": [
        "965d5e31ae90be5dca185dacd7b62c07"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R4",
      "type": "TREATS",
      "source_entity_id": "E7",
      "target_entity_id": "E6",
      "attributes": {
        "context": "therapeutic"
      },
      "confidence": 0.8,
      "evidence": "antidepressant effects",
      "source_chunk_ids": [
        "965d5e31ae90be5dca185dacd7b62c07"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R1",
      "type": "HAS_EVIDENCE",
      "source_entity_id": "E1",
      "target_entity_id": "E2",
      "attributes": {},
      "confidence": 0.85,
      "evidence": "Research by Helmut Wachtel demonstrated",
      "source_chunk_ids": [
        "932852e578657d1f1cdd15cd076ead6a"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R2",
      "type": "STUDIES",
      "source_entity_id": "E1",
      "target_entity_id": "E3",
      "attributes": {
        "role": "intervention"
      },
      "confidence": 0.9,
      "evidence": "demonstrated that the then-novel compound rolipram",
      "source_chunk_ids": [
        "932852e578657d1f1cdd15cd076ead6a"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R3",
      "type": "REPORTS",
      "source_entity_id": "E1",
      "target_entity_id": "E6",
      "attributes": {
        "outcome": "positive"
      },
      "confidence": 0.8,
      "evidence": "have CNS activity",
      "source_chunk_ids": [
        "932852e578657d1f1cdd15cd076ead6a"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R4",
      "type": "ACTS_ON",
      "source_entity_id": "E3",
      "target_entity_id": "E4",
      "attributes": {
        "action": "inhibits"
      },
      "confidence": 0.85,
      "evidence": "inhibitors of cAMP phosphodiesterase",
      "source_chunk_ids": [
        "932852e578657d1f1cdd15cd076ead6a"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R5",
      "type": "PRODUCES",
      "source_entity_id": "E6",
      "target_entity_id": "E7",
      "attributes": {},
      "confidence": 0.75,
      "evidence": "pattern of effects is indicative of antidepressant efficacy",
      "source_chunk_ids": [
        "932852e578657d1f1cdd15cd076ead6a"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R6",
      "type": "HAS_EVIDENCE",
      "source_entity_id": "E8",
      "target_entity_id": "E9",
      "attributes": {},
      "confidence": 0.7,
      "evidence": "borne out later in a clinical trial",
      "source_chunk_ids": [
        "932852e578657d1f1cdd15cd076ead6a"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R7",
      "type": "REPORTS",
      "source_entity_id": "E8",
      "target_entity_id": "E7",
      "attributes": {
        "outcome": "positive",
        "verification_needed": true
      },
      "confidence": 0.65,
      "evidence": "borne out later in a clinical trial",
      "source_chunk_ids": [
        "932852e578657d1f1cdd15cd076ead6a"
      ],
      "supporting_study_ids": [],
      "verified": false
    },
    {
      "id": "R8",
      "type": "TREATS",
      "source_entity_id": "E3",
      "target_entity_id": "E10",
      "attributes": {
        "context": "clinical"
      },
      "confidence": 0.7,
      "evidence": "therapeutic utility in depression",
      "source_chunk_ids": [
        "932852e578657d1f1cdd15cd076ead6a"
      ],
      "supporting_study_ids": [
        "E8"
      ],
      "verified": true
    },
    {
      "id": "R9",
      "type": "ACTS_ON",
      "source_entity_id": "E3",
      "target_entity_id": "E5",
      "attributes": {
        "action": "inhibits"
      },
      "confidence": 0.9,
      "evidence": "potent, highly selective inhibitor of type 4 PDE",
      "source_chunk_ids": [
        "932852e578657d1f1cdd15cd076ead6a"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R10",
      "type": "SUGGESTS",
      "source_entity_id": "E2",
      "target_entity_id": "E10",
      "attributes": {
        "mapping_type": "direct"
      },
      "confidence": 0.75,
      "evidence": "inhibitors of PDE4 might represent antidepressant drugs",
      "source_chunk_ids": [
        "932852e578657d1f1cdd15cd076ead6a"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R11",
      "type": "SUGGESTS",
      "source_entity_id": "E2",
      "target_entity_id": "E11",
      "attributes": {
        "mapping_type": "direct"
      },
      "confidence": 0.7,
      "evidence": "potential for treatment of inflammatory disorders",
      "source_chunk_ids": [
        "932852e578657d1f1cdd15cd076ead6a"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R12",
      "type": "SUGGESTS",
      "source_entity_id": "E2",
      "target_entity_id": "E12",
      "attributes": {
        "mapping_type": "direct"
      },
      "confidence": 0.7,
      "evidence": "potential for treatment of immunological disorders",
      "source_chunk_ids": [
        "932852e578657d1f1cdd15cd076ead6a"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R13",
      "type": "ACTS_ON",
      "source_entity_id": "E3",
      "target_entity_id": "E13",
      "attributes": {
        "action": "inhibits",
        "verification_needed": true
      },
      "confidence": 0.65,
      "evidence": "lack of highly selective inhibitors of PDE4 subtypes",
      "source_chunk_ids": [
        "932852e578657d1f1cdd15cd076ead6a"
      ],
      "supporting_study_ids": [],
      "verified": false
    },
    {
      "id": "R14",
      "type": "ACTS_ON",
      "source_entity_id": "E3",
      "target_entity_id": "E14",
      "attributes": {
        "action": "interacts with",
        "verification_needed": true
      },
      "confidence": 0.6,
      "evidence": "inhibitors interact with HARBS",
      "source_chunk_ids": [
        "932852e578657d1f1cdd15cd076ead6a"
      ],
      "supporting_study_ids": [],
      "verified": false
    },
    {
      "id": "R15",
      "type": "ACTS_ON",
      "source_entity_id": "E3",
      "target_entity_id": "E15",
      "attributes": {
        "action": "interacts with",
        "verification_needed": true
      },
      "confidence": 0.6,
      "evidence": "inhibitors interact with LARBS",
      "source_chunk_ids": [
        "932852e578657d1f1cdd15cd076ead6a"
      ],
      "supporting_study_ids": [],
      "verified": false
    },
    {
      "id": "R1",
      "type": "PRODUCES",
      "source_entity_id": "E1",
      "target_entity_id": "E6",
      "attributes": {
        "context": "brain involvement"
      },
      "confidence": 0.7,
      "evidence": "PDE4 is present in brain regions involved in reward",
      "source_chunk_ids": [
        "7f5a74ac13da75da462287b1cb003d32"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R2",
      "type": "PRODUCES",
      "source_entity_id": "E1",
      "target_entity_id": "E7",
      "attributes": {
        "context": "brain involvement"
      },
      "confidence": 0.7,
      "evidence": "PDE4 is present in brain regions involved in affect",
      "source_chunk_ids": [
        "7f5a74ac13da75da462287b1cb003d32"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R1",
      "type": "HAS_CLASS",
      "source_entity_id": "E1",
      "target_entity_id": "E2",
      "attributes": {},
      "confidence": 0.8,
      "evidence": "Rolipram and other PDE4 inhibitors",
      "source_chunk_ids": [
        "daf511dbaf73a527055607849218e6c4"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R2",
      "type": "HAS_CLASS",
      "source_entity_id": "E3",
      "target_entity_id": "E2",
      "attributes": {},
      "confidence": 0.75,
      "evidence": "PDE4 inhibitors [e.g. Ro201724",
      "source_chunk_ids": [
        "daf511dbaf73a527055607849218e6c4"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R3",
      "type": "HAS_CLASS",
      "source_entity_id": "E4",
      "target_entity_id": "E2",
      "attributes": {},
      "confidence": 0.75,
      "evidence": "PDE4 inhibitors [e.g. ... ICI63197]",
      "source_chunk_ids": [
        "daf511dbaf73a527055607849218e6c4"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R4",
      "type": "PRODUCES",
      "source_entity_id": "E1",
      "target_entity_id": "E5",
      "attributes": {},
      "confidence": 0.85,
      "evidence": "Rolipram ... produce antidepressant-like effects",
      "source_chunk_ids": [
        "daf511dbaf73a527055607849218e6c4"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R5",
      "type": "PRODUCES",
      "source_entity_id": "E2",
      "target_entity_id": "E5",
      "attributes": {},
      "confidence": 0.8,
      "evidence": "PDE4 inhibitors ... produce antidepressant-like effects",
      "source_chunk_ids": [
        "daf511dbaf73a527055607849218e6c4"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R1",
      "type": "PRODUCES",
      "source_entity_id": "E1",
      "target_entity_id": "E9",
      "attributes": {
        "verification_needed": true
      },
      "confidence": 0.65,
      "evidence": "effects typical of antidepressant drugs",
      "source_chunk_ids": [
        "9cf7c3476eaf50eb155077d28a3c7195"
      ],
      "supporting_study_ids": [],
      "verified": false
    },
    {
      "id": "R2",
      "type": "PRODUCES",
      "source_entity_id": "E2",
      "target_entity_id": "E9",
      "attributes": {
        "verification_needed": true
      },
      "confidence": 0.65,
      "evidence": "effects typical of antidepressant drugs",
      "source_chunk_ids": [
        "9cf7c3476eaf50eb155077d28a3c7195"
      ],
      "supporting_study_ids": [],
      "verified": false
    },
    {
      "id": "R3",
      "type": "PRODUCES",
      "source_entity_id": "E3",
      "target_entity_id": "E9",
      "attributes": {
        "verification_needed": true
      },
      "confidence": 0.65,
      "evidence": "effects typical of antidepressant drugs",
      "source_chunk_ids": [
        "9cf7c3476eaf50eb155077d28a3c7195"
      ],
      "supporting_study_ids": [],
      "verified": false
    },
    {
      "id": "R4",
      "type": "PRODUCES",
      "source_entity_id": "E4",
      "target_entity_id": "E9",
      "attributes": {
        "verification_needed": true
      },
      "confidence": 0.65,
      "evidence": "effects typical of antidepressant drugs",
      "source_chunk_ids": [
        "9cf7c3476eaf50eb155077d28a3c7195"
      ],
      "supporting_study_ids": [],
      "verified": false
    },
    {
      "id": "R5",
      "type": "PRODUCES",
      "source_entity_id": "E5",
      "target_entity_id": "E9",
      "attributes": {
        "verification_needed": true
      },
      "confidence": 0.65,
      "evidence": "effects typical of antidepressant drugs",
      "source_chunk_ids": [
        "9cf7c3476eaf50eb155077d28a3c7195"
      ],
      "supporting_study_ids": [],
      "verified": false
    },
    {
      "id": "R6",
      "type": "PRODUCES",
      "source_entity_id": "E6",
      "target_entity_id": "E9",
      "attributes": {
        "verification_needed": true
      },
      "confidence": 0.65,
      "evidence": "effects typical of antidepressant drugs",
      "source_chunk_ids": [
        "9cf7c3476eaf50eb155077d28a3c7195"
      ],
      "supporting_study_ids": [],
      "verified": false
    },
    {
      "id": "R7",
      "type": "PRODUCES",
      "source_entity_id": "E7",
      "target_entity_id": "E9",
      "attributes": {
        "verification_needed": true
      },
      "confidence": 0.65,
      "evidence": "effects typical of antidepressant drugs",
      "source_chunk_ids": [
        "9cf7c3476eaf50eb155077d28a3c7195"
      ],
      "supporting_study_ids": [],
      "verified": false
    },
    {
      "id": "R8",
      "type": "PRODUCES",
      "source_entity_id": "E8",
      "target_entity_id": "E9",
      "attributes": {
        "verification_needed": true
      },
      "confidence": 0.65,
      "evidence": "effects typical of antidepressant drugs",
      "source_chunk_ids": [
        "9cf7c3476eaf50eb155077d28a3c7195"
      ],
      "supporting_study_ids": [],
      "verified": false
    },
    {
      "id": "R9",
      "type": "PRODUCES",
      "source_entity_id": "E10",
      "target_entity_id": "E12",
      "attributes": {},
      "confidence": 0.7,
      "evidence": "PDE4 involved in CREB-mediated induction",
      "source_chunk_ids": [
        "9cf7c3476eaf50eb155077d28a3c7195"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R10",
      "type": "PRODUCES",
      "source_entity_id": "E11",
      "target_entity_id": "E12",
      "attributes": {},
      "confidence": 0.7,
      "evidence": "CREB-mediated induction of neurogenesis",
      "source_chunk_ids": [
        "9cf7c3476eaf50eb155077d28a3c7195"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R11",
      "type": "PRODUCES",
      "source_entity_id": "E13",
      "target_entity_id": "E14",
      "attributes": {
        "verification_needed": true
      },
      "confidence": 0.65,
      "evidence": "induce neurogenesis important in mediating effects",
      "source_chunk_ids": [
        "9cf7c3476eaf50eb155077d28a3c7195"
      ],
      "supporting_study_ids": [],
      "verified": false
    },
    {
      "id": "R1",
      "type": "ACTS_ON",
      "source_entity_id": "E4",
      "target_entity_id": "E2",
      "attributes": {
        "action": "inhibits"
      },
      "confidence": 0.8,
      "evidence": "PDE4 inhibitors",
      "source_chunk_ids": [
        "faa4b4cea1353cd24eecfad1b58d6bda"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R2",
      "type": "PRODUCES",
      "source_entity_id": "E4",
      "target_entity_id": "E3",
      "attributes": {},
      "confidence": 0.75,
      "evidence": "antidepressant effects of rolipram",
      "source_chunk_ids": [
        "faa4b4cea1353cd24eecfad1b58d6bda"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R3",
      "type": "CAUSES",
      "source_entity_id": "E4",
      "target_entity_id": "E5",
      "attributes": {
        "context": "clinical"
      },
      "confidence": 0.7,
      "evidence": "emetic actions",
      "source_chunk_ids": [
        "faa4b4cea1353cd24eecfad1b58d6bda"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R4",
      "type": "CAUSES",
      "source_entity_id": "E4",
      "target_entity_id": "E6",
      "attributes": {
        "context": "clinical"
      },
      "confidence": 0.7,
      "evidence": "sedative actions",
      "source_chunk_ids": [
        "faa4b4cea1353cd24eecfad1b58d6bda"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R1",
      "type": "PRODUCES",
      "source_entity_id": "E5",
      "target_entity_id": "E4",
      "attributes": {
        "context": "mechanistic"
      },
      "confidence": 0.7,
      "evidence": "Inhibition of PDE4 might produce antidepressant effects",
      "source_chunk_ids": [
        "86ecbea6e66d2e9eaa19330f2e576700"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R2",
      "type": "PRODUCES",
      "source_entity_id": "E5",
      "target_entity_id": "E3",
      "attributes": {
        "context": "mechanistic",
        "verification_needed": true
      },
      "confidence": 0.65,
      "evidence": "by altering noradrenaline-mediated neurotransmission",
      "source_chunk_ids": [
        "86ecbea6e66d2e9eaa19330f2e576700"
      ],
      "supporting_study_ids": [],
      "verified": false
    },
    {
      "id": "R1",
      "type": "ACTS_ON",
      "source_entity_id": "E4",
      "target_entity_id": "E2",
      "attributes": {
        "action": "enhances",
        "verification_needed": true
      },
      "confidence": 0.65,
      "evidence": "PDE4 inhibitors enhance aspects of 5-HT-mediated neurotransmission",
      "source_chunk_ids": [
        "21a98f83de243122f2a63ceebb9ace2a"
      ],
      "supporting_study_ids": [],
      "verified": false
    },
    {
      "id": "R2",
      "type": "PRODUCES",
      "source_entity_id": "E4",
      "target_entity_id": "E11",
      "attributes": {},
      "confidence": 0.7,
      "evidence": "PDE4 inhibitors enhance aspects",
      "source_chunk_ids": [
        "21a98f83de243122f2a63ceebb9ace2a"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R3",
      "type": "ACTS_ON",
      "source_entity_id": "E6",
      "target_entity_id": "E7",
      "attributes": {
        "action": "inhibits"
      },
      "confidence": 0.85,
      "evidence": "inhibitor of 5-HT reuptake such as fluoxetine",
      "source_chunk_ids": [
        "21a98f83de243122f2a63ceebb9ace2a"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R4",
      "type": "PRODUCES",
      "source_entity_id": "E6",
      "target_entity_id": "E12",
      "attributes": {},
      "confidence": 0.8,
      "evidence": "repeated treatment with fluoxetine increases expression",
      "source_chunk_ids": [
        "21a98f83de243122f2a63ceebb9ace2a"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R5",
      "type": "PRODUCES",
      "source_entity_id": "E12",
      "target_entity_id": "E13",
      "attributes": {
        "verification_needed": true
      },
      "confidence": 0.6,
      "evidence": "PDE4D activity is affected by phosphorylation",
      "source_chunk_ids": [
        "21a98f83de243122f2a63ceebb9ace2a"
      ],
      "supporting_study_ids": [],
      "verified": false
    },
    {
      "id": "R1",
      "type": "ACTS_ON",
      "source_entity_id": "E9",
      "target_entity_id": "E1",
      "attributes": {
        "action": "inhibits"
      },
      "confidence": 0.8,
      "evidence": "PDE4 is regulated by Rolipram (inhibitor)",
      "source_chunk_ids": [
        "2ff9a599199735e9334bd4ffc2b41627"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R2",
      "type": "PRODUCES",
      "source_entity_id": "E1",
      "target_entity_id": "E10",
      "attributes": {},
      "confidence": 0.7,
      "evidence": "PDE4A, PDE4B, and PDE4D interacting with Antidepressant",
      "source_chunk_ids": [
        "2ff9a599199735e9334bd4ffc2b41627"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R3",
      "type": "PRODUCES",
      "source_entity_id": "E1",
      "target_entity_id": "E11",
      "attributes": {},
      "confidence": 0.7,
      "evidence": "PDE4A, PDE4B, and PDE4D interacting with Memory enhancing",
      "source_chunk_ids": [
        "2ff9a599199735e9334bd4ffc2b41627"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R4",
      "type": "PRODUCES",
      "source_entity_id": "E1",
      "target_entity_id": "E12",
      "attributes": {},
      "confidence": 0.7,
      "evidence": "PDE4A, PDE4B, and PDE4D interacting with Emesis",
      "source_chunk_ids": [
        "2ff9a599199735e9334bd4ffc2b41627"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R1",
      "type": "PRODUCES",
      "source_entity_id": "E1",
      "target_entity_id": "E9",
      "attributes": {
        "action": "inhibition"
      },
      "confidence": 0.85,
      "evidence": "Inhibition of PDE4 increases cAMP-mediated signaling",
      "source_chunk_ids": [
        "d1b266a586f21cad7004d900e58c7267"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R2",
      "type": "PRODUCES",
      "source_entity_id": "E9",
      "target_entity_id": "E10",
      "attributes": {},
      "confidence": 0.7,
      "evidence": "antidepressant effects might be mediated via these signaling pathways",
      "source_chunk_ids": [
        "d1b266a586f21cad7004d900e58c7267"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R3",
      "type": "PRODUCES",
      "source_entity_id": "E9",
      "target_entity_id": "E11",
      "attributes": {},
      "confidence": 0.7,
      "evidence": "memory-enhancing effects might be mediated via these signaling pathways",
      "source_chunk_ids": [
        "d1b266a586f21cad7004d900e58c7267"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R1",
      "type": "ACTS_ON",
      "source_entity_id": "E1",
      "target_entity_id": "E2",
      "attributes": {
        "action": "involved in"
      },
      "confidence": 0.8,
      "evidence": "PDE4 in NMDA-receptor-mediated signaling",
      "source_chunk_ids": [
        "8a565dbf31f1453b967c49a5c540a569"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R2",
      "type": "PRODUCES",
      "source_entity_id": "E1",
      "target_entity_id": "E3",
      "attributes": {},
      "confidence": 0.75,
      "evidence": "PDE4 is implicated in antidepressant actions",
      "source_chunk_ids": [
        "8a565dbf31f1453b967c49a5c540a569"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R3",
      "type": "ACTS_ON",
      "source_entity_id": "E5",
      "target_entity_id": "E2",
      "attributes": {
        "action": "antagonist"
      },
      "confidence": 0.85,
      "evidence": "NMDA antagonists such as MK801",
      "source_chunk_ids": [
        "8a565dbf31f1453b967c49a5c540a569"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R4",
      "type": "PRODUCES",
      "source_entity_id": "E5",
      "target_entity_id": "E4",
      "attributes": {},
      "confidence": 0.8,
      "evidence": "MK801 are reported to produce antidepressant-like effects",
      "source_chunk_ids": [
        "8a565dbf31f1453b967c49a5c540a569"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R5",
      "type": "ACTS_ON",
      "source_entity_id": "E7",
      "target_entity_id": "E8",
      "attributes": {
        "action": "reverses"
      },
      "confidence": 0.85,
      "evidence": "rolipram has been shown to reverse memory deficits",
      "source_chunk_ids": [
        "8a565dbf31f1453b967c49a5c540a569"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R6",
      "type": "PRODUCES",
      "source_entity_id": "E2",
      "target_entity_id": "E11",
      "attributes": {
        "action": "increases"
      },
      "confidence": 0.85,
      "evidence": "NMDA receptors increases intracellular concentrations of cAMP",
      "source_chunk_ids": [
        "8a565dbf31f1453b967c49a5c540a569"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R7",
      "type": "PRODUCES",
      "source_entity_id": "E2",
      "target_entity_id": "E12",
      "attributes": {
        "action": "increases"
      },
      "confidence": 0.85,
      "evidence": "NMDA receptors increases intracellular concentrations of cGMP",
      "source_chunk_ids": [
        "8a565dbf31f1453b967c49a5c540a569"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R8",
      "type": "ACTS_ON",
      "source_entity_id": "E1",
      "target_entity_id": "E11",
      "attributes": {
        "action": "hydrolyzes"
      },
      "confidence": 0.8,
      "evidence": "cAMP formed by NMDA-receptor stimulation is hydrolyzed exclusively by PDE4",
      "source_chunk_ids": [
        "8a565dbf31f1453b967c49a5c540a569"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R9",
      "type": "ACTS_ON",
      "source_entity_id": "E13",
      "target_entity_id": "E12",
      "attributes": {
        "action": "hydrolyzes"
      },
      "confidence": 0.8,
      "evidence": "cGMP that forms is hydrolyzed by PDE2 only",
      "source_chunk_ids": [
        "8a565dbf31f1453b967c49a5c540a569"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R10",
      "type": "SUGGESTS",
      "source_entity_id": "E1",
      "target_entity_id": "E10",
      "attributes": {
        "mapping_type": "interpretive"
      },
      "confidence": 0.7,
      "evidence": "PDE4 in NMDA-receptor-mediated signaling might be related more to cognitive deficits",
      "source_chunk_ids": [
        "8a565dbf31f1453b967c49a5c540a569"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R11",
      "type": "SUGGESTS",
      "source_entity_id": "E10",
      "target_entity_id": "E9",
      "attributes": {
        "mapping_type": "direct"
      },
      "confidence": 0.85,
      "evidence": "cognitive deficits that occur in depression",
      "source_chunk_ids": [
        "8a565dbf31f1453b967c49a5c540a569"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R1",
      "type": "HAS_CLASS",
      "source_entity_id": "E2",
      "target_entity_id": "E1",
      "attributes": {},
      "confidence": 0.7,
      "evidence": "inhibitors, such as rolipram",
      "source_chunk_ids": [
        "a9bf951806a526ce7d2abe85a7c1b07a"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R2",
      "type": "HAS_CLASS",
      "source_entity_id": "E3",
      "target_entity_id": "E1",
      "attributes": {},
      "confidence": 0.7,
      "evidence": "inhibitors, such as Ro201724",
      "source_chunk_ids": [
        "a9bf951806a526ce7d2abe85a7c1b07a"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R3",
      "type": "ACTS_ON",
      "source_entity_id": "E2",
      "target_entity_id": "E4",
      "attributes": {
        "action": "inhibits"
      },
      "confidence": 0.8,
      "evidence": "inhibiting the four PDE4 subtypes",
      "source_chunk_ids": [
        "a9bf951806a526ce7d2abe85a7c1b07a"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R4",
      "type": "ACTS_ON",
      "source_entity_id": "E3",
      "target_entity_id": "E4",
      "attributes": {
        "action": "inhibits"
      },
      "confidence": 0.8,
      "evidence": "inhibiting the four PDE4 subtypes",
      "source_chunk_ids": [
        "a9bf951806a526ce7d2abe85a7c1b07a"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R5",
      "type": "PRODUCES",
      "source_entity_id": "E4",
      "target_entity_id": "E7",
      "attributes": {
        "verification_needed": true
      },
      "confidence": 0.65,
      "evidence": "roles of the PDE4 subtypes in antidepressant effects",
      "source_chunk_ids": [
        "a9bf951806a526ce7d2abe85a7c1b07a"
      ],
      "supporting_study_ids": [],
      "verified": false
    },
    {
      "id": "R6",
      "type": "STUDIES",
      "source_entity_id": "E8",
      "target_entity_id": "E5",
      "attributes": {
        "role": "target"
      },
      "confidence": 0.7,
      "evidence": "PDE4B-knockout lines",
      "source_chunk_ids": [
        "a9bf951806a526ce7d2abe85a7c1b07a"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R7",
      "type": "STUDIES",
      "source_entity_id": "E8",
      "target_entity_id": "E6",
      "attributes": {
        "role": "target"
      },
      "confidence": 0.7,
      "evidence": "PDE4D-knockout lines",
      "source_chunk_ids": [
        "a9bf951806a526ce7d2abe85a7c1b07a"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R8",
      "type": "REPORTS",
      "source_entity_id": "E8",
      "target_entity_id": "E7",
      "attributes": {
        "outcome": "assesses",
        "verification_needed": true
      },
      "confidence": 0.6,
      "evidence": "assess the relative roles in antidepressant effects",
      "source_chunk_ids": [
        "a9bf951806a526ce7d2abe85a7c1b07a"
      ],
      "supporting_study_ids": [],
      "verified": false
    },
    {
      "id": "R1",
      "type": "REPORTS",
      "source_entity_id": "E7",
      "target_entity_id": "E1",
      "attributes": {
        "outcome": "involves"
      },
      "confidence": 0.9,
      "evidence": "PDE4D-deficient mice",
      "source_chunk_ids": [
        "5491df562c325ae25574b24b75a967aa"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R2",
      "type": "REPORTS",
      "source_entity_id": "E7",
      "target_entity_id": "E2",
      "attributes": {
        "outcome": "observed"
      },
      "confidence": 0.85,
      "evidence": "exhibit an antidepressant-like profile",
      "source_chunk_ids": [
        "5491df562c325ae25574b24b75a967aa"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R3",
      "type": "PRODUCES",
      "source_entity_id": "E2",
      "target_entity_id": "E3",
      "attributes": {},
      "confidence": 0.8,
      "evidence": "evidenced by reduced immobility",
      "source_chunk_ids": [
        "5491df562c325ae25574b24b75a967aa"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R4",
      "type": "ACTS_ON",
      "source_entity_id": "E4",
      "target_entity_id": "E1",
      "attributes": {
        "action": "inhibits",
        "notes": "mediated by PDE4D subtype"
      },
      "confidence": 0.75,
      "evidence": "its actions are mediated by the PDE4D subtype",
      "source_chunk_ids": [
        "5491df562c325ae25574b24b75a967aa"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R5",
      "type": "REPORTS",
      "source_entity_id": "E7",
      "target_entity_id": "E4",
      "attributes": {
        "outcome": "tested"
      },
      "confidence": 0.8,
      "evidence": "rolipram causes minimal reduction",
      "source_chunk_ids": [
        "5491df562c325ae25574b24b75a967aa"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R6",
      "type": "REPORTS",
      "source_entity_id": "E7",
      "target_entity_id": "E5",
      "attributes": {
        "outcome": "tested"
      },
      "confidence": 0.7,
      "evidence": "desipramine administered",
      "source_chunk_ids": [
        "5491df562c325ae25574b24b75a967aa"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R7",
      "type": "REPORTS",
      "source_entity_id": "E7",
      "target_entity_id": "E6",
      "attributes": {
        "outcome": "tested"
      },
      "confidence": 0.7,
      "evidence": "fluoxetine administered",
      "source_chunk_ids": [
        "5491df562c325ae25574b24b75a967aa"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R8",
      "type": "HAS_EVIDENCE",
      "source_entity_id": "E7",
      "target_entity_id": "E8",
      "attributes": {},
      "confidence": 0.85,
      "evidence": "PDE4D-deficient mice exhibit",
      "source_chunk_ids": [
        "5491df562c325ae25574b24b75a967aa"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R1",
      "type": "ACTS_ON",
      "source_entity_id": "E1",
      "target_entity_id": "E3",
      "attributes": {
        "action": "enhances"
      },
      "confidence": 0.85,
      "evidence": "rolipram to enhance beta-adrenoceptor-mediated cAMP formation",
      "source_chunk_ids": [
        "3fcaa03a54b2f6cedb9f791441394f66"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R2",
      "type": "PRODUCES",
      "source_entity_id": "E1",
      "target_entity_id": "E6",
      "attributes": {},
      "confidence": 0.8,
      "evidence": "rolipram to enhance cAMP formation",
      "source_chunk_ids": [
        "3fcaa03a54b2f6cedb9f791441394f66"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R3",
      "type": "PRODUCES",
      "source_entity_id": "E2",
      "target_entity_id": "E7",
      "attributes": {
        "assertion": "refutes"
      },
      "confidence": 0.75,
      "evidence": "PDE4D-deficient mice diminished cAMP formation enhancement",
      "source_chunk_ids": [
        "3fcaa03a54b2f6cedb9f791441394f66"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R4",
      "type": "ACTS_ON",
      "source_entity_id": "E4",
      "target_entity_id": "E2",
      "attributes": {
        "action": "unknown",
        "assertion": "speculative",
        "verification_needed": true
      },
      "confidence": 0.6,
      "evidence": "PDE4D is not involved in their actions",
      "source_chunk_ids": [
        "3fcaa03a54b2f6cedb9f791441394f66"
      ],
      "supporting_study_ids": [],
      "verified": false
    },
    {
      "id": "R5",
      "type": "ACTS_ON",
      "source_entity_id": "E5",
      "target_entity_id": "E2",
      "attributes": {
        "action": "unknown",
        "assertion": "speculative",
        "verification_needed": true
      },
      "confidence": 0.6,
      "evidence": "PDE4D is not involved in their actions",
      "source_chunk_ids": [
        "3fcaa03a54b2f6cedb9f791441394f66"
      ],
      "supporting_study_ids": [],
      "verified": false
    },
    {
      "id": "R6",
      "type": "PRODUCES",
      "source_entity_id": "E4",
      "target_entity_id": "E8",
      "attributes": {
        "assertion": "speculative",
        "verification_needed": true
      },
      "confidence": 0.65,
      "evidence": "monoamine-uptake inhibitors produce effects by increasing cAMP formation",
      "source_chunk_ids": [
        "3fcaa03a54b2f6cedb9f791441394f66"
      ],
      "supporting_study_ids": [],
      "verified": false
    },
    {
      "id": "R7",
      "type": "PRODUCES",
      "source_entity_id": "E5",
      "target_entity_id": "E8",
      "attributes": {
        "assertion": "speculative",
        "verification_needed": true
      },
      "confidence": 0.65,
      "evidence": "monoamine-uptake inhibitors produce effects by increasing cAMP formation",
      "source_chunk_ids": [
        "3fcaa03a54b2f6cedb9f791441394f66"
      ],
      "supporting_study_ids": [],
      "verified": false
    },
    {
      "id": "R8",
      "type": "PRODUCES",
      "source_entity_id": "E2",
      "target_entity_id": "E9",
      "attributes": {
        "assertion": "speculative",
        "verification_needed": true
      },
      "confidence": 0.6,
      "evidence": "loss of PDE4D would enhance effects of desipramine and fluoxetine",
      "source_chunk_ids": [
        "3fcaa03a54b2f6cedb9f791441394f66"
      ],
      "supporting_study_ids": [],
      "verified": false
    },
    {
      "id": "R9",
      "type": "PRODUCES",
      "source_entity_id": "E2",
      "target_entity_id": "E10",
      "attributes": {
        "assertion": "speculative",
        "verification_needed": true
      },
      "confidence": 0.6,
      "evidence": "loss of PDE4D would increase potency of these drugs",
      "source_chunk_ids": [
        "3fcaa03a54b2f6cedb9f791441394f66"
      ],
      "supporting_study_ids": [],
      "verified": false
    },
    {
      "id": "R1",
      "type": "STUDIES",
      "source_entity_id": "E7",
      "target_entity_id": "E1",
      "attributes": {
        "role": "target"
      },
      "confidence": 0.7,
      "evidence": "PDE4B-deficient mice",
      "source_chunk_ids": [
        "71a1953f84ad5fcc11d2125c2c179e00"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R2",
      "type": "HAS_EVIDENCE",
      "source_entity_id": "E7",
      "target_entity_id": "E8",
      "attributes": {},
      "confidence": 0.7,
      "evidence": "preliminary results",
      "source_chunk_ids": [
        "71a1953f84ad5fcc11d2125c2c179e00"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R3",
      "type": "REPORTS",
      "source_entity_id": "E7",
      "target_entity_id": "E3",
      "attributes": {
        "outcome": "exhibits"
      },
      "confidence": 0.7,
      "evidence": "exhibit an antidepressant-like profile",
      "source_chunk_ids": [
        "71a1953f84ad5fcc11d2125c2c179e00"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R4",
      "type": "ACTS_ON",
      "source_entity_id": "E4",
      "target_entity_id": "E1",
      "attributes": {
        "action": "no significant effect",
        "outcome": "no_effect"
      },
      "confidence": 0.75,
      "evidence": "rolipram causes no significant, additional reduction",
      "source_chunk_ids": [
        "71a1953f84ad5fcc11d2125c2c179e00"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R5",
      "type": "ACTS_ON",
      "source_entity_id": "E5",
      "target_entity_id": "E1",
      "attributes": {
        "action": "no effect",
        "outcome": "no_effect"
      },
      "confidence": 0.8,
      "evidence": "desipramine produces no further antidepressant-like effects",
      "source_chunk_ids": [
        "71a1953f84ad5fcc11d2125c2c179e00"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R6",
      "type": "PRODUCES",
      "source_entity_id": "E1",
      "target_entity_id": "E3",
      "attributes": {},
      "confidence": 0.7,
      "evidence": "PDE4B-deficient mice exhibit an antidepressant-like profile",
      "source_chunk_ids": [
        "71a1953f84ad5fcc11d2125c2c179e00"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R1",
      "type": "PRODUCES",
      "source_entity_id": "E7",
      "target_entity_id": "E4",
      "attributes": {
        "context": "pharmacological"
      },
      "confidence": 0.85,
      "evidence": "antidepressant-like effects of PDE4 inhibitors",
      "source_chunk_ids": [
        "61fda0e6683450b82c7a2d8f19d254d5"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R2",
      "type": "TREATS",
      "source_entity_id": "E7",
      "target_entity_id": "E8",
      "attributes": {
        "context": "pharmacological"
      },
      "confidence": 0.75,
      "evidence": "antidepressant-like effects",
      "source_chunk_ids": [
        "61fda0e6683450b82c7a2d8f19d254d5"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R3",
      "type": "CAUSES",
      "source_entity_id": "E7",
      "target_entity_id": "E5",
      "attributes": {
        "context": "pharmacological"
      },
      "confidence": 0.8,
      "evidence": "side-effects of emesis",
      "source_chunk_ids": [
        "61fda0e6683450b82c7a2d8f19d254d5"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R4",
      "type": "CAUSES",
      "source_entity_id": "E7",
      "target_entity_id": "E6",
      "attributes": {
        "context": "pharmacological"
      },
      "confidence": 0.8,
      "evidence": "side-effects of ... sedation",
      "source_chunk_ids": [
        "61fda0e6683450b82c7a2d8f19d254d5"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R1",
      "type": "ACTS_ON",
      "source_entity_id": "E2",
      "target_entity_id": "E1",
      "attributes": {
        "action": "inhibits"
      },
      "confidence": 0.85,
      "evidence": "PDE4 inhibitors",
      "source_chunk_ids": [
        "caf80bdf725c1fa6209c0c2d12006214"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R2",
      "type": "ACTS_ON",
      "source_entity_id": "E2",
      "target_entity_id": "E3",
      "attributes": {
        "action": "binds",
        "measurement": {
          "value": 1,
          "unit": "nM",
          "measurement_type": "Ki",
          "notes": "high-affinity binding in brain membranes"
        }
      },
      "confidence": 0.75,
      "evidence": "binds with high affinity (K_i = 1-10 nM)",
      "source_chunk_ids": [
        "caf80bdf725c1fa6209c0c2d12006214"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R3",
      "type": "ACTS_ON",
      "source_entity_id": "E2",
      "target_entity_id": "E4",
      "attributes": {
        "action": "binds",
        "measurement": {
          "value": null,
          "unit": null,
          "measurement_type": "low-affinity",
          "notes": "little high-affinity binding in peripheral organs"
        }
      },
      "confidence": 0.7,
      "evidence": "little high-affinity binding in peripheral organs",
      "source_chunk_ids": [
        "caf80bdf725c1fa6209c0c2d12006214"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R1",
      "type": "ACTS_ON",
      "source_entity_id": "E2",
      "target_entity_id": "E1",
      "attributes": {
        "action": "binds",
        "measurement": {
          "value": 500,
          "unit": "fold",
          "measurement_type": "affinity difference",
          "notes": "high-affinity and low-affinity states differ ~500-fold in apparent Ki values"
        }
      },
      "confidence": 0.85,
      "evidence": "binds with two distinct affinity states that differ ~500-fold",
      "source_chunk_ids": [
        "50093827e7a3ffc2e25a0d18067a5338"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R2",
      "type": "ACTS_ON",
      "source_entity_id": "E3",
      "target_entity_id": "E1",
      "attributes": {
        "action": "binds",
        "measurement": {
          "value": null,
          "unit": null,
          "measurement_type": "affinity",
          "notes": "exhibits high, equal affinity for both affinity states"
        }
      },
      "confidence": 0.75,
      "evidence": "some drugs exhibit high, equal affinity for both affinity states (e.g. piclamilast)",
      "source_chunk_ids": [
        "50093827e7a3ffc2e25a0d18067a5338"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R1",
      "type": "ACTS_ON",
      "source_entity_id": "E1",
      "target_entity_id": "E2",
      "attributes": {
        "action": "binds"
      },
      "confidence": 0.85,
      "evidence": "binding to each affinity state",
      "source_chunk_ids": [
        "80eabf32513520a8d886aeb8c856efb4"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R2",
      "type": "ACTS_ON",
      "source_entity_id": "E1",
      "target_entity_id": "E3",
      "attributes": {
        "action": "binds"
      },
      "confidence": 0.85,
      "evidence": "binding to each affinity state",
      "source_chunk_ids": [
        "80eabf32513520a8d886aeb8c856efb4"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R3",
      "type": "PRODUCES",
      "source_entity_id": "E1",
      "target_entity_id": "E4",
      "attributes": {},
      "confidence": 0.75,
      "evidence": "producing some effects, such as induction of head twitches and tremor in mice",
      "source_chunk_ids": [
        "80eabf32513520a8d886aeb8c856efb4"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R4",
      "type": "PRODUCES",
      "source_entity_id": "E1",
      "target_entity_id": "E5",
      "attributes": {},
      "confidence": 0.75,
      "evidence": "producing some effects, such as ... emesis in ferrets",
      "source_chunk_ids": [
        "80eabf32513520a8d886aeb8c856efb4"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R5",
      "type": "PRODUCES",
      "source_entity_id": "E1",
      "target_entity_id": "E6",
      "attributes": {},
      "confidence": 0.75,
      "evidence": "other effects, including inhibition of mast cell degranulation",
      "source_chunk_ids": [
        "80eabf32513520a8d886aeb8c856efb4"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R6",
      "type": "PRODUCES",
      "source_entity_id": "E1",
      "target_entity_id": "E7",
      "attributes": {},
      "confidence": 0.75,
      "evidence": "other effects, including ... antigen-induced T-cell proliferation in guinea-pigs",
      "source_chunk_ids": [
        "80eabf32513520a8d886aeb8c856efb4"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R1",
      "type": "ACTS_ON",
      "source_entity_id": "E2",
      "target_entity_id": "E1",
      "attributes": {
        "action": "interacts with"
      },
      "confidence": 0.7,
      "evidence": "HARBS appears to be present in brain",
      "source_chunk_ids": [
        "bd5729556bfa08457465c1c27eaa40af"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R2",
      "type": "PRODUCES",
      "source_entity_id": "E7",
      "target_entity_id": "E6",
      "attributes": {
        "verification_needed": true
      },
      "confidence": 0.65,
      "evidence": "CNS effects of PDE4 inhibitors are mediated by the HARBS",
      "source_chunk_ids": [
        "bd5729556bfa08457465c1c27eaa40af"
      ],
      "supporting_study_ids": [],
      "verified": false
    },
    {
      "id": "R3",
      "type": "HAS_EVIDENCE",
      "source_entity_id": "E8",
      "target_entity_id": "E9",
      "attributes": {},
      "confidence": 0.7,
      "evidence": "inhibition of [^{3}H]-rolipram binding",
      "source_chunk_ids": [
        "bd5729556bfa08457465c1c27eaa40af"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R4",
      "type": "HAS_EVIDENCE",
      "source_entity_id": "E8",
      "target_entity_id": "E10",
      "attributes": {},
      "confidence": 0.7,
      "evidence": "forced-swim test in rats",
      "source_chunk_ids": [
        "bd5729556bfa08457465c1c27eaa40af"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R5",
      "type": "REPORTS",
      "source_entity_id": "E8",
      "target_entity_id": "E6",
      "attributes": {
        "outcome": "correlates"
      },
      "confidence": 0.75,
      "evidence": "relative potency correlates with inhibition of binding",
      "source_chunk_ids": [
        "bd5729556bfa08457465c1c27eaa40af"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R1",
      "type": "ACTS_ON",
      "source_entity_id": "E1",
      "target_entity_id": "E3",
      "attributes": {
        "action": "enhances"
      },
      "confidence": 0.7,
      "evidence": "noradrenaline-mediated actions",
      "source_chunk_ids": [
        "75b2c2fb00b45bdaa16e7d05ef8076c8"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R2",
      "type": "ACTS_ON",
      "source_entity_id": "E2",
      "target_entity_id": "E4",
      "attributes": {
        "action": "enhances"
      },
      "confidence": 0.7,
      "evidence": "5-HT-mediated actions",
      "source_chunk_ids": [
        "75b2c2fb00b45bdaa16e7d05ef8076c8"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R3",
      "type": "PRODUCES",
      "source_entity_id": "E1",
      "target_entity_id": "E6",
      "attributes": {
        "verification_needed": true
      },
      "confidence": 0.65,
      "evidence": "increases the HARBS",
      "source_chunk_ids": [
        "75b2c2fb00b45bdaa16e7d05ef8076c8"
      ],
      "supporting_study_ids": [],
      "verified": false
    },
    {
      "id": "R4",
      "type": "PRODUCES",
      "source_entity_id": "E2",
      "target_entity_id": "E6",
      "attributes": {
        "verification_needed": true
      },
      "confidence": 0.65,
      "evidence": "increases the HARBS",
      "source_chunk_ids": [
        "75b2c2fb00b45bdaa16e7d05ef8076c8"
      ],
      "supporting_study_ids": [],
      "verified": false
    },
    {
      "id": "R5",
      "type": "PRODUCES",
      "source_entity_id": "E1",
      "target_entity_id": "E7",
      "attributes": {
        "outcome": "no_effect",
        "verification_needed": true
      },
      "confidence": 0.65,
      "evidence": "not the LARBS",
      "source_chunk_ids": [
        "75b2c2fb00b45bdaa16e7d05ef8076c8"
      ],
      "supporting_study_ids": [],
      "verified": false
    },
    {
      "id": "R6",
      "type": "PRODUCES",
      "source_entity_id": "E2",
      "target_entity_id": "E7",
      "attributes": {
        "outcome": "no_effect",
        "verification_needed": true
      },
      "confidence": 0.65,
      "evidence": "not the LARBS",
      "source_chunk_ids": [
        "75b2c2fb00b45bdaa16e7d05ef8076c8"
      ],
      "supporting_study_ids": [],
      "verified": false
    },
    {
      "id": "R7",
      "type": "PRODUCES",
      "source_entity_id": "E6",
      "target_entity_id": "E8",
      "attributes": {
        "verification_needed": true
      },
      "confidence": 0.6,
      "evidence": "antidepressant effects are secondary",
      "source_chunk_ids": [
        "75b2c2fb00b45bdaa16e7d05ef8076c8"
      ],
      "supporting_study_ids": [],
      "verified": false
    },
    {
      "id": "R8",
      "type": "PRODUCES",
      "source_entity_id": "E3",
      "target_entity_id": "E8",
      "attributes": {
        "verification_needed": true
      },
      "confidence": 0.6,
      "evidence": "noradrenaline-mediated neurotransmission",
      "source_chunk_ids": [
        "75b2c2fb00b45bdaa16e7d05ef8076c8"
      ],
      "supporting_study_ids": [],
      "verified": false
    },
    {
      "id": "R9",
      "type": "PRODUCES",
      "source_entity_id": "E4",
      "target_entity_id": "E8",
      "attributes": {
        "verification_needed": true
      },
      "confidence": 0.6,
      "evidence": "5-HT-mediated neurotransmission",
      "source_chunk_ids": [
        "75b2c2fb00b45bdaa16e7d05ef8076c8"
      ],
      "supporting_study_ids": [],
      "verified": false
    },
    {
      "id": "R1",
      "type": "PRODUCES",
      "source_entity_id": "E4",
      "target_entity_id": "E5",
      "attributes": {},
      "confidence": 0.7,
      "evidence": "alter cAMP hydrolysis... alter PDE4-related CNS function",
      "source_chunk_ids": [
        "48c14a07868915458502117c76e8d780"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R2",
      "type": "SUGGESTS",
      "source_entity_id": "E5",
      "target_entity_id": "E6",
      "attributes": {
        "mapping_type": "interpretive",
        "verification_needed": true
      },
      "confidence": 0.65,
      "evidence": "mediation of antidepressant activity",
      "source_chunk_ids": [
        "48c14a07868915458502117c76e8d780"
      ],
      "supporting_study_ids": [],
      "verified": false
    },
    {
      "id": "R1",
      "type": "ACTS_ON",
      "source_entity_id": "E1",
      "target_entity_id": "E2",
      "attributes": {
        "action": "inhibits"
      },
      "confidence": 0.9,
      "evidence": "selective adenosine cyclic 3',5'-monophosphate phosphodiesterase inhibitors",
      "source_chunk_ids": [
        "8a033d3d806294e79fa7a7bf320bafad"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R2",
      "type": "PRODUCES",
      "source_entity_id": "E1",
      "target_entity_id": "E3",
      "attributes": {},
      "confidence": 0.8,
      "evidence": "behavioral alterations in rats induced by rolipram",
      "source_chunk_ids": [
        "8a033d3d806294e79fa7a7bf320bafad"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R3",
      "type": "PRODUCES",
      "source_entity_id": "E1",
      "target_entity_id": "E4",
      "attributes": {},
      "confidence": 0.85,
      "evidence": "Potential antidepressant activity of rolipram",
      "source_chunk_ids": [
        "8a033d3d806294e79fa7a7bf320bafad"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R4",
      "type": "HAS_EVIDENCE",
      "source_entity_id": "E5",
      "target_entity_id": "E8",
      "attributes": {},
      "confidence": 0.8,
      "evidence": "in vitro studies mentioned",
      "source_chunk_ids": [
        "8a033d3d806294e79fa7a7bf320bafad"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R5",
      "type": "HAS_EVIDENCE",
      "source_entity_id": "E7",
      "target_entity_id": "E9",
      "attributes": {},
      "confidence": 0.85,
      "evidence": "phase II study of the antidepressant effect of rolipram",
      "source_chunk_ids": [
        "8a033d3d806294e79fa7a7bf320bafad"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R6",
      "type": "STUDIES",
      "source_entity_id": "E5",
      "target_entity_id": "E1",
      "attributes": {
        "role": "intervention"
      },
      "confidence": 0.9,
      "evidence": "Wachtel, H. (1982) Characteristic behavioral alterations in rats induced by rolipram",
      "source_chunk_ids": [
        "8a033d3d806294e79fa7a7bf320bafad"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R7",
      "type": "STUDIES",
      "source_entity_id": "E6",
      "target_entity_id": "E1",
      "attributes": {
        "role": "intervention"
      },
      "confidence": 0.9,
      "evidence": "Wachtel, H. (1983) Potential antidepressant activity of rolipram",
      "source_chunk_ids": [
        "8a033d3d806294e79fa7a7bf320bafad"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R8",
      "type": "STUDIES",
      "source_entity_id": "E7",
      "target_entity_id": "E1",
      "attributes": {
        "role": "intervention"
      },
      "confidence": 0.9,
      "evidence": "Zeller, E. (1984) Results of a phase II study of the antidepressant effect of rolipram",
      "source_chunk_ids": [
        "8a033d3d806294e79fa7a7bf320bafad"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R9",
      "type": "REPORTS",
      "source_entity_id": "E5",
      "target_entity_id": "E3",
      "attributes": {
        "outcome": "induces"
      },
      "confidence": 0.8,
      "evidence": "Characteristic behavioral alterations in rats induced by rolipram",
      "source_chunk_ids": [
        "8a033d3d806294e79fa7a7bf320bafad"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R10",
      "type": "REPORTS",
      "source_entity_id": "E6",
      "target_entity_id": "E4",
      "attributes": {
        "outcome": "potential"
      },
      "confidence": 0.85,
      "evidence": "Potential antidepressant activity of rolipram",
      "source_chunk_ids": [
        "8a033d3d806294e79fa7a7bf320bafad"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R11",
      "type": "REPORTS",
      "source_entity_id": "E7",
      "target_entity_id": "E10",
      "attributes": {
        "outcome": "antidepressant effect"
      },
      "confidence": 0.9,
      "evidence": "Results of a phase II study of the antidepressant effect of rolipram",
      "source_chunk_ids": [
        "8a033d3d806294e79fa7a7bf320bafad"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R12",
      "type": "TREATS",
      "source_entity_id": "E1",
      "target_entity_id": "E10",
      "attributes": {
        "context": "clinical"
      },
      "confidence": 0.8,
      "evidence": "antidepressant effect of rolipram",
      "source_chunk_ids": [
        "8a033d3d806294e79fa7a7bf320bafad"
      ],
      "supporting_study_ids": [
        "E7"
      ],
      "verified": true
    },
    {
      "id": "R13",
      "type": "CAUSES",
      "source_entity_id": "E1",
      "target_entity_id": "E11",
      "attributes": {
        "context": "clinical"
      },
      "confidence": 0.7,
      "evidence": "Emesis induced by inhibitors of type IV cyclic nucleotide phosphodiesterase",
      "source_chunk_ids": [
        "8a033d3d806294e79fa7a7bf320bafad"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R14",
      "type": "PRODUCES",
      "source_entity_id": "E1",
      "target_entity_id": "E12",
      "attributes": {},
      "confidence": 0.75,
      "evidence": "sedative effects of rolipram in rats",
      "source_chunk_ids": [
        "8a033d3d806294e79fa7a7bf320bafad"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R1",
      "type": "REPORTS",
      "source_entity_id": "E9",
      "target_entity_id": "E7",
      "attributes": {
        "outcome": "improves"
      },
      "confidence": 0.75,
      "evidence": "reverses memory deficits",
      "source_chunk_ids": [
        "387a41515771a03ed7e7cdefcf4c33ff"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R2",
      "type": "REPORTS",
      "source_entity_id": "E10",
      "target_entity_id": "E8",
      "attributes": {
        "outcome": "improves"
      },
      "confidence": 0.7,
      "evidence": "Antidepressant-like profile",
      "source_chunk_ids": [
        "387a41515771a03ed7e7cdefcf4c33ff"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R3",
      "type": "HAS_EVIDENCE",
      "source_entity_id": "E9",
      "target_entity_id": "E11",
      "attributes": {
        "verification_needed": true
      },
      "confidence": 0.65,
      "evidence": "in vitro",
      "source_chunk_ids": [
        "387a41515771a03ed7e7cdefcf4c33ff"
      ],
      "supporting_study_ids": [],
      "verified": false
    },
    {
      "id": "R4",
      "type": "HAS_EVIDENCE",
      "source_entity_id": "E10",
      "target_entity_id": "E12",
      "attributes": {
        "verification_needed": true
      },
      "confidence": 0.65,
      "evidence": "mice deficient",
      "source_chunk_ids": [
        "387a41515771a03ed7e7cdefcf4c33ff"
      ],
      "supporting_study_ids": [],
      "verified": false
    },
    {
      "id": "R5",
      "type": "STUDIES",
      "source_entity_id": "E9",
      "target_entity_id": "E1",
      "attributes": {
        "role": "target"
      },
      "confidence": 0.7,
      "evidence": "PDE4",
      "source_chunk_ids": [
        "387a41515771a03ed7e7cdefcf4c33ff"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R6",
      "type": "STUDIES",
      "source_entity_id": "E10",
      "target_entity_id": "E4",
      "attributes": {
        "role": "target"
      },
      "confidence": 0.7,
      "evidence": "PDE4D",
      "source_chunk_ids": [
        "387a41515771a03ed7e7cdefcf4c33ff"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R7",
      "type": "SUGGESTS",
      "source_entity_id": "E1",
      "target_entity_id": "E6",
      "attributes": {
        "mapping_type": "interpretive",
        "verification_needed": true
      },
      "confidence": 0.6,
      "evidence": "antidepressant actions",
      "source_chunk_ids": [
        "387a41515771a03ed7e7cdefcf4c33ff"
      ],
      "supporting_study_ids": [],
      "verified": false
    },
    {
      "id": "R8",
      "type": "SUGGESTS",
      "source_entity_id": "E5",
      "target_entity_id": "E6",
      "attributes": {
        "mapping_type": "interpretive",
        "verification_needed": true
      },
      "confidence": 0.6,
      "evidence": "antidepressant actions",
      "source_chunk_ids": [
        "387a41515771a03ed7e7cdefcf4c33ff"
      ],
      "supporting_study_ids": [],
      "verified": false
    }
  ]
}